{ "meta": { "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.", "terms": "https://open.fda.gov/terms/", "license": "https://open.fda.gov/license/", "last_updated": "2025-09-19", "results": { "skip": 0, "limit": 1, "total": 1 } }, "results": [ { "codes": [ { "uuid": "c4023b6e-0ce7-4b88-8edb-f0098d7496a1", "code": "B01AC06", "comments": "ATC|BLOOD AND BLOOD FORMING ORGANS|ANTITHROMBOTIC AGENTS|ANTITHROMBOTIC AGENTS|Platelet aggregation inhibitors excl. heparin|acetylsalicylic acid", "type": "PRIMARY", "url": "http://www.whocc.no/atc_ddd_index/?code=B01AC06&showdescription=yes", "code_system": "WHO-ATC", "references": [ "7fe598a7-d0bd-4eb6-8427-6742e7156e05" ] }, { "uuid": "2f6c5688-0631-4167-9a67-aa13398eae32", "code": "A01AD05", "comments": "ATC|ALIMENTARY TRACT AND METABOLISM|STOMATOLOGICAL PREPARATIONS|STOMATOLOGICAL PREPARATIONS|Other agents for local oral treatment|acetylsalicylic acid", "type": "PRIMARY", "url": "http://www.whocc.no/atc_ddd_index/?code=A01AD05&showdescription=yes", "code_system": "WHO-ATC", "references": [ "7fe598a7-d0bd-4eb6-8427-6742e7156e05" ] }, { "uuid": "86021902-3725-4588-a490-6b3102b720fc", "code": "N02BA01", "comments": "ATC|NERVOUS SYSTEM|ANALGESICS|OTHER ANALGESICS AND ANTIPYRETICS|Salicylic acid and derivatives|acetylsalicylic acid", "type": "PRIMARY", "url": "http://www.whocc.no/atc_ddd_index/?code=N02BA01&showdescription=yes", "code_system": "WHO-ATC", "references": [ "7fe598a7-d0bd-4eb6-8427-6742e7156e05" ] }, { "uuid": "aad35419-e7a5-4c7b-9519-85d1632c7dcf", "code": "N0000175722", "comments": "Established Pharmacologic Class [EPC]|Nonsteroidal Anti-inflammatory Drug [EPC]", "type": "PRIMARY", "url": "https://nciterms.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=VA_NDFRT&code=N0000175722", "code_system": "NDF-RT", "references": [ "7fe598a7-d0bd-4eb6-8427-6742e7156e05" ] }, { "uuid": "d2efd642-0b04-4b3b-abd2-349baabd2dd3", "code": "N0000175721", "comments": "Chemical Ingredients [Chemical/Ingredient]|Chemical Classes for Pharmacologic Classification [Chemical/Ingredient]|Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient]", "type": "PRIMARY", "url": "https://nciterms.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=VA_NDFRT&code=N0000175721", "code_system": "NDF-RT", "references": [ "7fe598a7-d0bd-4eb6-8427-6742e7156e05" ] }, { "uuid": "640b0e93-2e7b-441d-8d64-4fd3fddb44e8", "code": "N0000000160", "comments": "Cellular or Molecular Interactions [MoA]|Enzyme Interactions [MoA]|Enzyme Inhibitors [MoA]|Cyclooxygenase Inhibitors [MoA]", "type": "PRIMARY", "url": "https://nciterms.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=VA_NDFRT&code=N0000000160", "code_system": "NDF-RT", "references": [ "7fe598a7-d0bd-4eb6-8427-6742e7156e05" ] }, { "uuid": "5d8a303b-b967-4b0d-b472-d5c5c1314c65", "code": "N0000008836", "comments": "Physiological Effects [PE]|Generalized Systemic Effects [PE]|Immunologic Activity Alteration [PE]|Immunologically Active Molecule Production Alteration [PE]|Decreased Immunologically Active Molecule Production [PE]|Decreased Lipid Derived Immunologically Active Molecule Production [PE]|Decreased Eicosanoid Production [PE]|Decreased Prostaglandin Production [PE]", "type": "PRIMARY", "url": "https://nciterms.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=VA_NDFRT&code=N0000008836", "code_system": "NDF-RT", "references": [ "7fe598a7-d0bd-4eb6-8427-6742e7156e05" ] }, { "uuid": "67de1aa0-d6b1-4fed-bf1f-9bfaafd0b76c", "code": "N0000008836", "comments": "Physiological Effects [PE]|Generalized Systemic Effects [PE]|Immunologic Activity Alteration [PE]|Decreased Immunologic Activity [PE]|Decreased Immunologically Active Molecule Production [PE]|Decreased Lipid Derived Immunologically Active Molecule Production [PE]|Decreased Eicosanoid Production [PE]|Decreased Prostaglandin Production [PE]", "type": "PRIMARY", "url": "https://nciterms.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=VA_NDFRT&code=N0000008836", "code_system": "NDF-RT", "references": [ "7fe598a7-d0bd-4eb6-8427-6742e7156e05" ] }, { "uuid": "3315fbe0-8a5e-476d-8f23-dca2d6087636", "code": "QM01BA03", "comments": "VATC|ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS|ANTIINFLAMMATORY/ANTIRHEUMATIC AGENTS IN COMBINATION|Antiinflammatory/antirheumatic agents in combination with corticosteroids|acetylsalicylic acid and corticosteroids", "type": "PRIMARY", "url": "http://www.whocc.no/atcvet/atcvet_index/?code=QM01BA03&showdescription=yes", "code_system": "WHO-VATC", "references": [ "7fe598a7-d0bd-4eb6-8427-6742e7156e05" ] }, { "uuid": "d9bc0bf7-478d-4dd0-8f91-cb1f0bb9ed22", "code": "QC10BX01", "comments": "VATC|LIPID MODIFYING AGENTS|LIPID MODIFYING AGENTS, COMBINATIONS|HMG CoA reductase inhibitors, other combinations|simvastatin and acetylsalicylic acid", "type": "PRIMARY", "url": "http://www.whocc.no/atcvet/atcvet_index/?code=QC10BX01&showdescription=yes", "code_system": "WHO-VATC", "references": [ "7fe598a7-d0bd-4eb6-8427-6742e7156e05" ] }, { "uuid": "9b2902d3-db93-4121-9bf7-7c5f18c9d8e5", "code": "QC10BX02", "comments": "VATC|LIPID MODIFYING AGENTS|LIPID MODIFYING AGENTS, COMBINATIONS|HMG CoA reductase inhibitors, other combinations|pravastatin and acetylsalicylic acid", "type": "PRIMARY", "url": "http://www.whocc.no/atcvet/atcvet_index/?code=QC10BX02&showdescription=yes", "code_system": "WHO-VATC", "references": [ "7fe598a7-d0bd-4eb6-8427-6742e7156e05" ] }, { "uuid": "f63cb1da-10cd-4fac-989f-584013b9ed6d", "code": "QC10BX04", "comments": "VATC|LIPID MODIFYING AGENTS|LIPID MODIFYING AGENTS, COMBINATIONS|HMG CoA reductase inhibitors, other combinations|simvastatin, acetylsalicylic acid and ramipril", "type": "PRIMARY", "url": "http://www.whocc.no/atcvet/atcvet_index/?code=QC10BX04&showdescription=yes", "code_system": "WHO-VATC", "references": [ "7fe598a7-d0bd-4eb6-8427-6742e7156e05" ] }, { "uuid": "596d82dc-decd-4650-b4bb-5cf30c656263", "code": "QC10BX05", "comments": "VATC|LIPID MODIFYING AGENTS|LIPID MODIFYING AGENTS, COMBINATIONS|HMG CoA reductase inhibitors, other combinations|rosuvastatin and acetylsalicylic acid", "type": "PRIMARY", "url": "http://www.whocc.no/atcvet/atcvet_index/?code=QC10BX05&showdescription=yes", "code_system": "WHO-VATC", "references": [ "7fe598a7-d0bd-4eb6-8427-6742e7156e05" ] }, { "uuid": "51371efd-4172-480a-8db4-c3d38063957e", "code": "QN02BA71", "comments": "VATC|ANALGESICS|OTHER ANALGESICS AND ANTIPYRETICS|Salicylic acid and derivatives|acetylsalicylic acid, combinations with psycholeptics", "type": "PRIMARY", "url": "http://www.whocc.no/atcvet/atcvet_index/?code=QN02BA71&showdescription=yes", "code_system": "WHO-VATC", "references": [ "7fe598a7-d0bd-4eb6-8427-6742e7156e05" ] }, { "uuid": "1c7f6a62-8261-40c0-a9f6-d58260af2ffb", "code": "QB01AC56", "comments": "VATC|ANTITHROMBOTIC AGENTS|ANTITHROMBOTIC AGENTS|Platelet aggregation inhibitors, excl. heparin|acetylsalicylic acid and esomeprazole", "type": "PRIMARY", "url": "http://www.whocc.no/atcvet/atcvet_index/?code=QB01AC56&showdescription=yes", "code_system": "WHO-VATC", "references": [ "7fe598a7-d0bd-4eb6-8427-6742e7156e05" ] }, { "uuid": "ca1296f1-ca2e-4244-afa0-1992b44fce06", "code": "QA01AD05", "comments": "VATC|STOMATOLOGICAL PREPARATIONS|STOMATOLOGICAL PREPARATIONS|Other agents for local oral treatment|acetylsalicylic acid", "type": "PRIMARY", "url": "http://www.whocc.no/atcvet/atcvet_index/?code=QA01AD05&showdescription=yes", "code_system": "WHO-VATC", "references": [ "7fe598a7-d0bd-4eb6-8427-6742e7156e05" ] }, { "uuid": "f0f598e0-9429-4110-a46e-c60cd1f1abd7", "code": "QN02BA01", "comments": "VATC|ANALGESICS|OTHER ANALGESICS AND ANTIPYRETICS|Salicylic acid and derivatives|acetylsalicylic acid", "type": "PRIMARY", "url": "http://www.whocc.no/atcvet/atcvet_index/?code=QN02BA01&showdescription=yes", "code_system": "WHO-VATC", "references": [ "7fe598a7-d0bd-4eb6-8427-6742e7156e05" ] }, { "uuid": "155f7e8e-14f8-4352-ab80-f146f2f7ca36", "code": "QN02BA51", "comments": "VATC|ANALGESICS|OTHER ANALGESICS AND ANTIPYRETICS|Salicylic acid and derivatives|acetylsalicylic acid, combinations excl. psycholeptics", "type": "PRIMARY", "url": "http://www.whocc.no/atcvet/atcvet_index/?code=QN02BA51&showdescription=yes", "code_system": "WHO-VATC", "references": [ "7fe598a7-d0bd-4eb6-8427-6742e7156e05" ] }, { "uuid": "9ecfcafa-8aef-49a9-b21b-5a0f94866669", "code": "50-78-2", "type": "PRIMARY", "url": "https://commonchemistry.cas.org/detail?cas_rn=50-78-2", "code_system": "CAS", "references": [ "7fe598a7-d0bd-4eb6-8427-6742e7156e05", "c46d623b-70b3-4c50-85ec-79bc9533a268" ] }, { "uuid": "77febc39-7d32-42f3-a4fe-83a159ff5076", "code": "C287", "type": "PRIMARY", "url": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C287", "code_system": "NCI_THESAURUS", "references": [ "7fe598a7-d0bd-4eb6-8427-6742e7156e05" ] }, { "uuid": "20b69f52-03e9-48ff-97e7-f63572bd28b3", "code": "NBK548900", "comments": "LiverTox|Analgesic|Mild-Moderate Pain|Salicylate", "type": "PRIMARY", "url": "https://www.ncbi.nlm.nih.gov/books/NBK548900/", "code_system": "LIVERTOX", "references": [ "928c0335-4c17-0364-8f39-f0ba8cb359f4" ] }, { "uuid": "17a4ac02-9c46-41b4-80c5-c544212cf562", "code": "D001241", "type": "PRIMARY", "url": "http://www.ncbi.nlm.nih.gov/mesh/68001241", "code_system": "MESH", "references": [ "7fe598a7-d0bd-4eb6-8427-6742e7156e05" ] }, { "uuid": "e6439cbf-f144-411b-b95f-13943ab250d6", "code": "2.1", "comments": "WHO ESSENTIAL MEDICINES LIST|Analgesics, antipyretics, non-steroidal anti-inflammatory medicines (NSAIMs), medicines used to treat gout and disease modifying agents in rheumatoid disorders (DMARDs)|Non-opioids and non-steroidal anti-inflammatory medicines (NSAIMs)", "type": "PRIMARY", "url": "http://prais.paho.org/medicine/19/?section=34#type60", "code_system": "WHO-ESSENTIAL MEDICINES LIST", "references": [ "7fe598a7-d0bd-4eb6-8427-6742e7156e05" ] }, { "uuid": "c5b01253-82f7-4efb-953e-96e74b3092b1", "code": "ASPIRIN", "type": "PRIMARY", "url": "https://en.wikipedia.org/wiki/Aspirin", "code_system": "WIKIPEDIA", "references": [ "7fe598a7-d0bd-4eb6-8427-6742e7156e05" ] }, { "uuid": "0f4c868d-c8e4-462b-ab6a-6cd9dc5dd9a2", "code": "21 CFR 343.12", "comments": "PART 343 -- INTERNAL ANALGESIC, ANTIPYRETIC, AND ANTIRHEUMATIC DRUG PRODUCTS FOR OVER-THE-COUNTER HUMAN USE|Subpart B--Active Ingredients|Sec. 343.12 Cardiovascular active ingredients.", "type": "PRIMARY", "url": "http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfCFR/CFRSearch.cfm?fr=343.12", "code_system": "CFR", "references": [ "7fe598a7-d0bd-4eb6-8427-6742e7156e05" ] }, { "uuid": "0d10f32d-a67f-434b-9074-b3158112afad", "code": "21 CFR 343.13", "comments": "PART 343 -- INTERNAL ANALGESIC, ANTIPYRETIC, AND ANTIRHEUMATIC DRUG PRODUCTS FOR OVER-THE-COUNTER HUMAN USE|Subpart B--Active Ingredients|Sec. 343.13 Rheumatologic active ingredients.", "type": "PRIMARY", "url": "http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfCFR/CFRSearch.cfm?fr=343.13", "code_system": "CFR", "references": [ "7fe598a7-d0bd-4eb6-8427-6742e7156e05" ] }, { "uuid": "65dbf325-c6ec-4f5b-9ebd-b4bb22e0421b", "code": "12.5", "comments": "WHO ESSENTIAL MEDICINES LIST|Cardiovascular medicines|Antithrombotic medicines", "type": "PRIMARY", "url": "http://prais.paho.org/medicine/19/?section=95#type63", "code_system": "WHO-ESSENTIAL MEDICINES LIST", "references": [ "7fe598a7-d0bd-4eb6-8427-6742e7156e05" ] }, { "uuid": "e2d2afa9-e9f8-4c2a-b5b7-4dd724f5bbbb", "code": "7.1", "comments": "WHO ESSENTIAL MEDICINES LIST|Antimigraine medicines|For treatment of acute attack", "type": "PRIMARY", "url": "http://prais.paho.org/medicine/19/?section=75#type62", "code_system": "WHO-ESSENTIAL MEDICINES LIST", "references": [ "7fe598a7-d0bd-4eb6-8427-6742e7156e05" ] }, { "uuid": "3fe6c6c9-4e95-4e3e-96fe-761412753c28", "code": "C10BX04", "comments": "ATC|CARDIOVASCULAR SYSTEM|LIPID MODIFYING AGENTS|LIPID MODIFYING AGENTS, COMBINATIONS|HMG CoA reductase inhibitors, other combinations|simvastatin, acetylsalicylic acid and ramipril", "type": "PRIMARY", "url": "http://www.whocc.no/atc_ddd_index/?code=C10BX04&showdescription=yes", "code_system": "WHO-ATC", "references": [ "7fe598a7-d0bd-4eb6-8427-6742e7156e05" ] }, { "uuid": "257da66e-7b6f-4e9b-9f7d-ffe709a7423a", "code": "C10BX05", "comments": "ATC|CARDIOVASCULAR SYSTEM|LIPID MODIFYING AGENTS|LIPID MODIFYING AGENTS, COMBINATIONS|HMG CoA reductase inhibitors, other combinations|rosuvastatin and acetylsalicylic acid", "type": "PRIMARY", "url": "http://www.whocc.no/atc_ddd_index/?code=C10BX05&showdescription=yes", "code_system": "WHO-ATC", "references": [ "7fe598a7-d0bd-4eb6-8427-6742e7156e05" ] }, { "uuid": "c244f724-f6d9-47ef-b9dd-053ba4241151", "code": "B01AC56", "comments": "ATC|BLOOD AND BLOOD FORMING ORGANS|ANTITHROMBOTIC AGENTS|ANTITHROMBOTIC AGENTS|Platelet aggregation inhibitors excl. heparin|acetylsalicylic acid and esomeprazole", "type": "PRIMARY", "url": "http://www.whocc.no/atc_ddd_index/?code=B01AC56&showdescription=yes", "code_system": "WHO-ATC", "references": [ "7fe598a7-d0bd-4eb6-8427-6742e7156e05" ] }, { "uuid": "349982d5-bb5d-4ccf-9744-45a5b2c8775b", "code": "M01BA03", "comments": "ATC|MUSCULO-SKELETAL SYSTEM|ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS|ANTIINFLAMMATORY/ANTIRHEUMATIC AGENTS IN COMBINATION|Antiinflammatory/antirheumatic agents in combination with corticosteroids|acetylsalicylic acid and corticosteroids", "type": "PRIMARY", "url": "http://www.whocc.no/atc_ddd_index/?code=M01BA03&showdescription=yes", "code_system": "WHO-ATC", "references": [ "7fe598a7-d0bd-4eb6-8427-6742e7156e05" ] }, { "uuid": "c314d9f9-028a-4318-9215-95d1f4315553", "code": "N02BA51", "comments": "ATC|NERVOUS SYSTEM|ANALGESICS|OTHER ANALGESICS AND ANTIPYRETICS|Salicylic acid and derivatives|acetylsalicylic acid, combinations excl. psycholeptics", "type": "PRIMARY", "url": "http://www.whocc.no/atc_ddd_index/?code=N02BA51&showdescription=yes", "code_system": "WHO-ATC", "references": [ "7fe598a7-d0bd-4eb6-8427-6742e7156e05" ] }, { "uuid": "84d166cb-5654-403a-8a70-0a722a7b9803", "code": "N02BA71", "comments": "ATC|NERVOUS SYSTEM|ANALGESICS|OTHER ANALGESICS AND ANTIPYRETICS|Salicylic acid and derivatives|acetylsalicylic acid, combinations with psycholeptics", "type": "PRIMARY", "url": "http://www.whocc.no/atc_ddd_index/?code=N02BA71&showdescription=yes", "code_system": "WHO-ATC", "references": [ "7fe598a7-d0bd-4eb6-8427-6742e7156e05" ] }, { "uuid": "1978181c-d544-4137-a5c4-f5fc6a6bdb50", "code": "C10BX01", "comments": "ATC|CARDIOVASCULAR SYSTEM|LIPID MODIFYING AGENTS|LIPID MODIFYING AGENTS, COMBINATIONS|HMG CoA reductase inhibitors, other combinations|simvastatin and acetylsalicylic acid", "type": "PRIMARY", "url": "http://www.whocc.no/atc_ddd_index/?code=C10BX01&showdescription=yes", "code_system": "WHO-ATC", "references": [ "7fe598a7-d0bd-4eb6-8427-6742e7156e05" ] }, { "uuid": "cd85d503-08e6-4429-8acf-45aad4bfc034", "code": "C10BX02", "comments": "ATC|CARDIOVASCULAR SYSTEM|LIPID MODIFYING AGENTS|LIPID MODIFYING AGENTS, COMBINATIONS|HMG CoA reductase inhibitors, other combinations|pravastatin and acetylsalicylic acid", "type": "PRIMARY", "url": "http://www.whocc.no/atc_ddd_index/?code=C10BX02&showdescription=yes", "code_system": "WHO-ATC", "references": [ "7fe598a7-d0bd-4eb6-8427-6742e7156e05" ] }, { "uuid": "54df5748-2c03-4fff-a5a7-28a7b8734a9f", "code": "QB01AC06", "comments": "VATC|ANTITHROMBOTIC AGENTS|ANTITHROMBOTIC AGENTS|Platelet aggregation inhibitors, excl. heparin|acetylsalicylic acid", "type": "PRIMARY", "url": "http://www.whocc.no/atcvet/atcvet_index/?code=QB01AC06&showdescription=yes", "code_system": "WHO-VATC", "references": [ "7fe598a7-d0bd-4eb6-8427-6742e7156e05" ] }, { "uuid": "dfe6ccb0-a72e-4312-8860-c714a699fd44", "code": "129061", "comments": "EPA PESTICIDE|CONVENTIONAL CHEMICAL", "type": "PRIMARY", "url": "http://iaspub.epa.gov/apex/pesticides/f?p=CHEMICALSEARCH:3:0::NO:21,3,31,7,12,25:P3_XCHEMICAL_ID:1031", "code_system": "EPA PESTICIDE CODE", "references": [ "7fe598a7-d0bd-4eb6-8427-6742e7156e05" ] }, { "uuid": "583dca07-b3b1-4376-a8b1-c81e2eb04502", "code": "DUOPLAVIN (AUTHORIZED: ACUTE CORONARY SYNDROME)", "comments": "EMA EPAR|DISEASES|CARDIOVASCULAR DISEASES|HEART DISEASES|MYOCARDIAL ISCHEMIA|ACUTE CORONARY SYNDROME", "type": "PRIMARY", "url": "http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/001143/human_med_001325.jsp&mid=WC0b01ac058001d124", "code_system": "EMA ASSESSMENT REPORTS", "references": [ "7fe598a7-d0bd-4eb6-8427-6742e7156e05" ] }, { "uuid": "f4a078e7-240d-49d3-b4bd-ce3ac294fff1", "code": "DUOCOVER (AUTHORIZED: ACUTE CORONARY SYNDROME)", "comments": "EMA EPAR|DISEASES|CARDIOVASCULAR DISEASES|HEART DISEASES|MYOCARDIAL ISCHEMIA|ACUTE CORONARY SYNDROME", "type": "PRIMARY", "url": "http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/001144/human_med_001326.jsp&mid=WC0b01ac058001d124", "code_system": "EMA ASSESSMENT REPORTS", "references": [ "7fe598a7-d0bd-4eb6-8427-6742e7156e05" ] }, { "uuid": "43b256e7-398c-431d-9093-b2a7492b5619", "code": "CLOPIDOGREL/ACETYLSALICYLIC ACID (AUTHORIZED: ACUTE CORONARY SYNDROME)", "comments": "EMA EPAR|DISEASES|CARDIOVASCULAR DISEASES|HEART DISEASES|MYOCARDIAL ISCHEMIA|ACUTE CORONARY SYNDROME", "type": "PRIMARY", "url": "http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/002272/human_med_001791.jsp&mid=WC0b01ac058001d124", "code_system": "EMA ASSESSMENT REPORTS", "references": [ "7fe598a7-d0bd-4eb6-8427-6742e7156e05" ] }, { "uuid": "4b926c35-37e2-4c37-83a8-cd00f5297d83", "code": "200-064-1", "type": "PRIMARY", "url": "https://echa.europa.eu/substance-information/-/substanceinfo/100.000.059", "code_system": "ECHA (EC/EINECS)", "references": [ "7fe598a7-d0bd-4eb6-8427-6742e7156e05" ] }, { "uuid": "64e846a8-649d-439b-8edd-cc9f2a8f1d9a", "code": "DUOPLAVIN (AUTHORIZED: MYOCARDIAL INFARCTION)", "comments": "EMA EPAR|DISEASES|CARDIOVASCULAR DISEASES|HEART DISEASES|MYOCARDIAL ISCHEMIA|MYOCARDIAL INFARCTION", "type": "PRIMARY", "url": "http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/001143/human_med_001325.jsp&mid=WC0b01ac058001d124", "code_system": "EMA ASSESSMENT REPORTS", "references": [ "7fe598a7-d0bd-4eb6-8427-6742e7156e05" ] }, { "uuid": "334ec2ad-8a9b-46fb-86ff-61dd6dbe933d", "code": "DUOCOVER (AUTHORIZED: MYOCARDIAL INFARCTION)", "comments": "EMA EPAR|DISEASES|CARDIOVASCULAR DISEASES|HEART DISEASES|MYOCARDIAL ISCHEMIA|MYOCARDIAL INFARCTION", "type": "PRIMARY", "url": "http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/001144/human_med_001326.jsp&mid=WC0b01ac058001d124", "code_system": "EMA ASSESSMENT REPORTS", "references": [ "7fe598a7-d0bd-4eb6-8427-6742e7156e05" ] }, { "uuid": "46992b86-c864-4ffe-a68b-c243cf5d60c5", "code": "CLOPIDOGREL/ACETYLSALICYCLIC ACID (AUTHORIZED: MYOCARDIAL INFARCTION)", "comments": "EMA EPAR|DISEASES|CARDIOVASCULAR DISEASES|HEART DISEASES|MYOCARDIAL ISCHEMIA|MYOCARDIAL INFARCTION", "type": "PRIMARY", "url": "http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/002272/human_med_001791.jsp&mid=WC0b01ac058001d124", "code_system": "EMA ASSESSMENT REPORTS", "references": [ "7fe598a7-d0bd-4eb6-8427-6742e7156e05" ] }, { "uuid": "b6e86d65-10af-4d6f-9fb5-6a699e2486cc", "code": "4139", "type": "PRIMARY", "url": "http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4139", "code_system": "IUPHAR", "references": [ "7fe598a7-d0bd-4eb6-8427-6742e7156e05" ] }, { "uuid": "c66ade9d-63da-479d-bd28-851e134cfea2", "code": "ASPIRIN", "comments": "Description: Colourless crystals or a white, crystalline powder; odourless or almost odourless. Solubility: Soluble in about 300 parts of water; freely soluble in ethanol (~750 g/l) TS; soluble in ether R. Category: Analgesic; antipyretic. Storage: Acetylsalicylic acid should be kept in a tightly closed container, protected from light. Additional information: Even in the absence of light, Acetylsalicylic acid is gradually degraded on exposure to a humid atmosphere, the decomposition being faster at higher temperatures. Definition: Acetylsalicylic acid contains not less than 99.0% and not more than 100.5% of C9H8O4, calculated with reference to the dried substance.", "type": "PRIMARY", "url": "http://apps.who.int/phint/pdf/b/Jb.6.1.5.pdf", "code_system": "WHO INTERNATIONAL PHARMACOPEIA", "references": [ "7fe598a7-d0bd-4eb6-8427-6742e7156e05" ] }, { "uuid": "ae21596a-bf48-45db-a0fa-d16907583cf6", "code": "m2111", "comments": "Merck Index", "type": "PRIMARY", "url": "https://merckindex.rsc.org/monographs/m2111?q=authorize", "code_system": "MERCK INDEX", "references": [ "7fe598a7-d0bd-4eb6-8427-6742e7156e05" ] }, { "uuid": "a1c175d5-d0d7-4495-9c2f-46b5b84468ed", "code": "91101", "type": "ALTERNATIVE", "url": "https://rxnav.nlm.nih.gov/REST/rxcui/91101/allProperties.xml?prop=all", "code_system": "RXCUI", "references": [ "7fe598a7-d0bd-4eb6-8427-6742e7156e05" ] }, { "uuid": "9b238332-910a-4291-b9bf-a66aa079099b", "code": "1191", "type": "PRIMARY", "url": "https://rxnav.nlm.nih.gov/REST/rxcui/1191/allProperties.xml?prop=all", "code_system": "RXCUI", "references": [ "7fe598a7-d0bd-4eb6-8427-6742e7156e05" ] }, { "uuid": "08f6f535-d27d-44d2-b50f-57d838de41c1", "code": "DB00945", "type": "PRIMARY", "url": "http://www.drugbank.ca/drugs/DB00945", "code_system": "DRUG BANK", "references": [ "7fe598a7-d0bd-4eb6-8427-6742e7156e05" ] }, { "uuid": "ae0ed312-d3fe-4cea-baf1-c549f7bda5c0", "code": "SUB12730MIG", "type": "PRIMARY", "code_system": "EVMPD", "references": [ "7fe598a7-d0bd-4eb6-8427-6742e7156e05" ] }, { "uuid": "af9e4eff-197c-4533-afb5-a07f73b64277", "code": "21 CFR 520.1409", "comments": "SUBCHAPTER E--ANIMAL DRUGS, FEEDS, AND RELATED PRODUCTS|PART 520 ORAL DOSAGE FORM NEW ANIMAL DRUGS|Sec. 520.1409 Methylprednisolone and aspirin.", "type": "PRIMARY", "url": "http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=520.1409", "code_system": "CFR", "references": [ "7fe598a7-d0bd-4eb6-8427-6742e7156e05" ] }, { "uuid": "e3c53aa7-652e-4097-9b87-10738d65fdc2", "code": "CHEMBL25", "type": "PRIMARY", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL25", "code_system": "ChEMBL", "references": [ "7fe598a7-d0bd-4eb6-8427-6742e7156e05" ] }, { "uuid": "b4928ada-9c88-42a6-bd09-b680c20c1c66", "code": "B01AC08", "comments": "ATC|BLOOD AND BLOOD FORMING ORGANS|ANTITHROMBOTIC AGENTS|ANTITHROMBOTIC AGENTS|Platelet aggregation inhibitors excl. heparin|carbasalate calcium", "type": "PRIMARY", "url": "http://www.whocc.no/atc_ddd_index/?code=B01AC08&showdescription=yes", "code_system": "WHO-ATC", "references": [ "7fe598a7-d0bd-4eb6-8427-6742e7156e05" ] }, { "uuid": "c6179f86-7237-40fa-8ae9-5071eb1b38ea", "code": "C10BX06", "comments": "ATC|CARDIOVASCULAR SYSTEM|LIPID MODIFYING AGENTS|LIPID MODIFYING AGENTS, COMBINATIONS|HMG CoA reductase inhibitors, other combinations|atorvastatin, acetylsalicylic acid and ramipril", "type": "PRIMARY", "url": "http://www.whocc.no/atc_ddd_index/?code=C10BX06&showdescription=yes", "code_system": "WHO-ATC", "references": [ "7fe598a7-d0bd-4eb6-8427-6742e7156e05" ] }, { "uuid": "a3a68501-19c9-4d1a-93a3-06f5c617ffd6", "code": "C10BX08", "comments": "ATC|CARDIOVASCULAR SYSTEM|LIPID MODIFYING AGENTS|LIPID MODIFYING AGENTS, COMBINATIONS|HMG CoA reductase inhibitors, other combinations|atorvastatin and acetylsalicylic acid", "type": "PRIMARY", "url": "http://www.whocc.no/atc_ddd_index/?code=C10BX08&showdescription=yes", "code_system": "WHO-ATC", "references": [ "7fe598a7-d0bd-4eb6-8427-6742e7156e05" ] }, { "uuid": "c77ffa10-9381-40f9-8662-aa97c23dd15b", "code": "N02BA15", "comments": "ATC|NERVOUS SYSTEM|ANALGESICS|OTHER ANALGESICS AND ANTIPYRETICS|Salicylic acid and derivatives|carbasalate calcium", "type": "PRIMARY", "url": "http://www.whocc.no/atc_ddd_index/?code=N02BA15&showdescription=yes", "code_system": "WHO-ATC", "references": [ "7fe598a7-d0bd-4eb6-8427-6742e7156e05" ] }, { "uuid": "fdd3288a-4b3f-4bba-a6c8-d840402ee145", "code": "N02BA65", "comments": "ATC|NERVOUS SYSTEM|ANALGESICS|OTHER ANALGESICS AND ANTIPYRETICS|Salicylic acid and derivatives|carbasalate calcium combinations excl. psycholeptics", "type": "PRIMARY", "url": "http://www.whocc.no/atc_ddd_index/?code=N02BA65&showdescription=yes", "code_system": "WHO-ATC", "references": [ "7fe598a7-d0bd-4eb6-8427-6742e7156e05" ] }, { "uuid": "51e4a060-1493-4555-a282-045dd71a6f68", "code": "2244", "type": "PRIMARY", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/2244", "code_system": "PUBCHEM", "references": [ "7fe598a7-d0bd-4eb6-8427-6742e7156e05" ] }, { "uuid": "8d1ae41f-8b5e-b96c-e8ae-b921a9facb2d", "code": "652", "type": "PRIMARY", "url": "https://pubchem.ncbi.nlm.nih.gov/source/hsdb/652", "code_system": "HSDB", "references": [ "f823da75-6cf7-9b20-ab9f-21969eb0691d" ] }, { "uuid": "e4bee99b-9fbe-1a7a-1fec-dfc6f526914a", "code": "DTXSID5020108", "type": "PRIMARY", "url": "https://comptox.epa.gov/dashboard/chemical/details/DTXSID5020108", "code_system": "EPA CompTox", "references": [ "e42d822d-ae63-de9f-7e90-372c4646c77d" ] }, { "uuid": "de620d7d-9a89-0aa7-10a9-0758f443c2a5", "code": "N02AJ18", "comments": "ATC|NERVOUS SYSTEM|ANALGESICS|OPIOIDS|Opioids in combination with non-opioid analgesics|oxycodone and acetylsalicylic acid", "type": "PRIMARY", "url": "http://www.whocc.no/atc_ddd_index/?code=N02AJ18&showdescription=yes", "code_system": "WHO-ATC" }, { "uuid": "4de6c699-9caa-81bd-9bf9-3475d682baaa", "code": "N02AJ02", "comments": "ATC|NERVOUS SYSTEM|ANALGESICS|OPIOIDS|Opioids in combination with non-opioid analgesics|dihydrocodeine and acetylsalicylic acid", "type": "PRIMARY", "url": "http://www.whocc.no/atc_ddd_index/?code=N02AJ02&showdescription=yes", "code_system": "WHO-ATC" }, { "uuid": "d72f22d9-0921-690a-0413-96dd99df6a09", "code": "N02AJ07", "comments": "ATC|NERVOUS SYSTEM|ANALGESICS|OPIOIDS|Opioids in combination with non-opioid analgesics|codeine and acetylsalicylic acid", "type": "PRIMARY", "url": "http://www.whocc.no/atc_ddd_index/?code=N02AJ07&showdescription=yes", "code_system": "WHO-ATC" }, { "uuid": "ee55b7bf-caa9-c905-26c8-fc22eca68963", "code": "C07FX04", "comments": "ATC|CARDIOVASCULAR SYSTEM|BETA BLOCKING AGENTS|BETA BLOCKING AGENTS, OTHER COMBINATIONS|Beta blocking agents, other combinations|bisoprolol and acetylsalicylic acid", "type": "PRIMARY", "url": "http://www.whocc.no/atc_ddd_index/?code=C07FX04&showdescription=yes", "code_system": "WHO-ATC" }, { "uuid": "02993f14-aa8c-b78d-df34-4d572f50698d", "code": "C07FX02", "comments": "ATC|CARDIOVASCULAR SYSTEM|BETA BLOCKING AGENTS|BETA BLOCKING AGENTS, OTHER COMBINATIONS|Beta blocking agents, other combinations|sotalol and acetylsalicylic acid", "type": "PRIMARY", "url": "http://www.whocc.no/atc_ddd_index/?code=C07FX02&showdescription=yes", "code_system": "WHO-ATC" }, { "uuid": "ecddbbc7-3eb1-57a9-66c3-3949dac47a2a", "code": "C07FX03", "comments": "ATC|CARDIOVASCULAR SYSTEM|BETA BLOCKING AGENTS|BETA BLOCKING AGENTS, OTHER COMBINATIONS|Beta blocking agents, other combinations|metoprolol and acetylsalicylic acid", "type": "PRIMARY", "url": "http://www.whocc.no/atc_ddd_index/?code=C07FX03&showdescription=yes", "code_system": "WHO-ATC" }, { "uuid": "eb33d766-4ba9-4542-94ef-f776ac77e6d5", "code": "21 CFR 341.40", "comments": "PART 341 -- COLD, COUGH, ALLERGY, BRONCHODILATOR, AND ANTIASTHMATIC DRUG PRODUCTS FOR OVER-THE-COUNTER HUMAN USE|Subpart B--Active Ingredients|Sec. 341.40 Permitted combinations of active ingredients.", "type": "PRIMARY", "url": "https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=341.40", "code_system": "CFR" }, { "uuid": "cf5d19b8-51b8-276b-cd79-be01da893466", "code": "C10BX12", "comments": "ATC|CARDIOVASCULAR SYSTEM|LIPID MODIFYING AGENTS|LIPID MODIFYING AGENTS, COMBINATIONS|HMG CoA reductase inhibitors, other combinations|atorvastatin, acetylsalicylic acid and perindopril", "type": "PRIMARY", "url": "http://www.whocc.no/atc_ddd_index/?code=C10BX12&showdescription=yes", "code_system": "WHO-ATC" }, { "uuid": "d67b9224-dd4f-0ece-7a5b-e2e1618b299d", "code": "N0000175578", "comments": "Established Pharmacologic Class [EPC]|Platelet Aggregation Inhibitor [EPC]", "type": "PRIMARY", "url": "https://nciterms.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=VA_NDFRT&code=N0000175578", "code_system": "NDF-RT", "references": [ "928c0335-4c17-0364-8f39-f0ba8cb359f4" ] }, { "uuid": "9eed09e6-04a3-07ee-9576-0426ea5c2833", "code": "607917", "comments": "ORPHAN DRUG|Designated|Treatment of multiple sclerosis in patients who experience dimethyl fumarate flushing", "type": "PRIMARY", "url": "https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=607917", "code_system": "FDA ORPHAN DRUG", "references": [ "928c0335-4c17-0364-8f39-f0ba8cb359f4" ] }, { "uuid": "c278603e-37b9-1941-de6a-c41e897e84a0", "code": "EU/3/04/208", "comments": "EU ORPHAN DRUG|Positive|Treatment of polycythaemia vera", "type": "PRIMARY", "url": "https://www.ema.europa.eu/en/medicines/human/orphan-designations/eu304208", "code_system": "EU-Orphan Drug", "references": [ "928c0335-4c17-0364-8f39-f0ba8cb359f4" ] }, { "uuid": "e3946a50-f81b-d9fa-73ed-505806024bec", "code": "Aspirin", "type": "PRIMARY", "url": "https://www.ncbi.nlm.nih.gov/books/n/lactmed/LM332/", "code_system": "LACTMED", "references": [ "928c0335-4c17-0364-8f39-f0ba8cb359f4" ] }, { "uuid": "3cdc2e75-cabf-fa1e-c514-dee7924d36b8", "code": "724719", "comments": "ORPHAN DRUG|Designated|Treatment of patients with multiple sclerosis who experience the fumarate flush", "type": "PRIMARY", "url": "https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=724719", "code_system": "FDA ORPHAN DRUG", "references": [ "928c0335-4c17-0364-8f39-f0ba8cb359f4" ] }, { "uuid": "a06069dc-c7fb-3622-39c5-b77d13bb8098", "code": "74", "type": "PRIMARY", "url": "https://drugcentral.org/drugcard/74", "code_system": "DRUG CENTRAL", "references": [ "928c0335-4c17-0364-8f39-f0ba8cb359f4" ] }, { "uuid": "81fecbc4-bb29-49b8-8f5a-ac73516df8ea", "code": "R16CO5Y76E", "type": "PRIMARY", "code_system": "FDA UNII" }, { "uuid": "4ef8aae3-207a-7adc-8600-5a49f305ee6c", "code": "764120", "comments": "ORPHAN DRUG|Designated|Treatment of Kawasaki Disease", "type": "PRIMARY", "url": "https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=764120", "code_system": "FDA ORPHAN DRUG", "references": [ "928c0335-4c17-0364-8f39-f0ba8cb359f4" ] }, { "uuid": "931b613f-f057-b3b9-8298-2d0388b48c8a", "code": "724619", "comments": "ORPHAN DRUG|Designated|Treatment of patients with multiple sclerosis who experience the fumarate flush", "type": "PRIMARY", "url": "https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=724619", "code_system": "FDA ORPHAN DRUG", "references": [ "928c0335-4c17-0364-8f39-f0ba8cb359f4" ] }, { "uuid": "dfc5af66-6668-f74d-6404-6a28b7e760f3", "code": "15365", "type": "PRIMARY", "url": "https://www.ebi.ac.uk/chebi/chebiOntology.do?chebiId=CHEBI:15365", "code_system": "CHEBI", "references": [ "928c0335-4c17-0364-8f39-f0ba8cb359f4" ] }, { "uuid": "0a961196-b583-df05-b166-7a2f27fd8423", "code": "1044006", "type": "PRIMARY", "url": "https://store.usp.org/product/1044006", "code_system": "RS_ITEM_NUM", "references": [ "928c0335-4c17-0364-8f39-f0ba8cb359f4" ] }, { "uuid": "36afa9f7-258a-d7cf-f5a8-5ecdd19601c1", "code": "100000092077", "type": "PRIMARY", "code_system": "SMS_ID", "references": [ "95de6bd3-ac85-e2f7-996d-b5dbf3eca53e" ] }, { "uuid": "df6e9f19-c1dc-7cb5-3d4c-40bfb2f4e906", "code": "27223", "type": "PRIMARY", "url": "https://dtp.cancer.gov/dtpstandard/servlet/dwindex?searchtype=NSC&outputformat=html&searchlist=27223", "code_system": "NSC", "references": [ "39ac848f-b389-b203-2dd0-815a67ccf0ed" ] }, { "uuid": "4b0fa353-fc18-59fc-c820-ccb5b71ef725", "code": "R16CO5Y76E", "type": "PRIMARY", "url": "https://dailymed.nlm.nih.gov/dailymed/search.cfm?adv=1&query=R16CO5Y76E", "code_system": "DAILYMED", "references": [ "55472576-1b16-bed7-7e3f-670a0f46e820" ] }, { "uuid": "e425e234-86b3-27fe-39c1-eb4a914a0138", "code": "406186", "type": "PRIMARY", "url": "https://dtp.cancer.gov/dtpstandard/servlet/dwindex?searchtype=NSC&outputformat=html&searchlist=406186", "code_system": "NSC", "references": [ "39ac848f-b389-b203-2dd0-815a67ccf0ed" ] } ], "substance_class": "chemical", "references": [ { "uuid": "b795c9a5-b1e7-4092-9e4e-d167d97e73ef", "citation": "EP 6.5", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN", "PUBLIC_DOMAIN_RELEASE", "AUTO_SELECTED" ] }, { "uuid": "919c5a16-f3ac-4b69-8379-603f07c4d74e", "citation": "USP Dictionary 2011", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "0fedf8bf-9112-4ae7-a876-63aab5fb0ac4", "citation": "USP Dictionary 2010", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "9bff8ba8-0ef5-4c4d-97de-48ec020106b7", "citation": "USP DICTIONARY 2008", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "7c51c2b1-c5f9-4c91-a806-69d7f24a4570", "citation": "HPUS 2004", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "f4dfdbd4-ea02-4b6b-a6ff-22ab95cb9bed", "citation": "USP DICTIONARY 2010", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "46a42348-c88b-408d-b596-a27280aff449", "citation": "fda_srs", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "d80b788d-5afd-46c9-b8d8-5fad1dd7d946", "citation": "HPUS", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "2cfd4ae8-b563-4eb8-8583-d161bd6a6889", "citation": "HPUS 2011", "doc_type": "HOMEOPATHIC PHARMACOPOEIA US", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "6b443371-95be-47a4-901e-9c314a8fb5db", "citation": "USP 33", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "fda2dc61-1264-40af-8758-3390e4d60ad6", "citation": "EP 7.2", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "46e82f2b-8ec5-4d3a-8039-62ba0f7ab34d", "citation": "Drugs@FDA 2011", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "5aa6dab6-399a-42e6-842f-e6f848c7b832", "citation": "Drugs@FDA 2012", "doc_type": "DRUGS@FDA", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "c814e853-bd01-4f1f-b23a-38686fbf7c90", "citation": "ORANGE BOOK 2011", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "747bac63-454a-481c-b7e2-6f6db0bee5c9", "citation": "MARTINDALE 2011", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "a2bacf49-c3ab-42b1-948e-4caf9d13dcc6", "citation": "MERCK INDEX", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "b3e56dca-af76-4b98-a9b4-243cc1bf6eb6", "citation": "FDA SRS 2011", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "dd19a315-71b2-45a2-a337-5c64b26e4586", "citation": "EMA", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "18815669-0ccb-4d9f-b665-41bd6a024220", "citation": "PCPC", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "b3548777-047f-44d3-9c55-4909a0fde423", "citation": "rxnorm", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "3f43d255-788b-4df8-b924-cc25dfedb171", "citation": "HSDB", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "098f0f09-2036-4008-a870-f473a32fc45b", "citation": "USP/NF", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "a9fd4df5-0685-47c5-8cae-52b7564e7d54", "citation": "WHO-IP", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "d64e9fda-15d4-440e-b9b4-eaaeb6d61dd7", "citation": "WHO-DD", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "c2c31c52-cf50-477b-b020-aa85b4cfc4d4", "citation": "NDF-RT", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "d059d77b-1f6c-4c77-9d67-7fa1c56deac5", "citation": "http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/001143/human_med_001325.", "url": "http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/001143/human_med_001325.", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "64d12b0f-0d9d-4896-8770-b827ea3128ff", "citation": "http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/001144/human_med_001326.", "url": "http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/001144/human_med_001326.", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "5ec89d1e-64a6-4148-8801-b5c0b4ad39fa", "citation": "http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/002272/human_med_001791.", "url": "http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/002272/human_med_001791.", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "6e4e22a6-0d29-4532-960e-9d99bda9fad8", "citation": "FDA-SRS", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "7da2f850-3e18-4d09-92c2-128028795de0", "citation": "http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=4c2a1403-3862-1efd-0a91-444989222b37", "url": "http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=4c2a1403-3862-1efd-0a91-444989222b37", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "745256bc-b919-4ff3-b3f2-e6ff4c6c7e77", "citation": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=73f74f6d-e624-4551-8924-1c747ffb2140", "url": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=73f74f6d-e624-4551-8924-1c747ffb2140", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "8a6afa6e-1bdb-4b33-b673-a1e239123a0e", "citation": "https://clinicaltrials.gov/ct2/show/NCT01117636", "url": "https://clinicaltrials.gov/ct2/show/NCT01117636", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "7fe598a7-d0bd-4eb6-8427-6742e7156e05", "citation": "SRS CODE IMPORT", "doc_type": "SRS", "public_domain": true, "document_date": 1493389714000, "tags": [ "NOMEN" ] }, { "uuid": "3b38330d-93b5-4c7c-bf99-1032b869c1db", "citation": "BIOL. PHARM. BULL. 27(5) 706?709 (2004)", "url": "https://www.jstage.jst.go.jp/article/bpb/27/5/27_5_706/_pdf", "doc_type": "JOURNAL ARTICLE", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "f99118ca-88f6-407e-83b0-90e5770b2c0a", "citation": "HTTPS://WWW.JSTAGE.JST.GO.JP/ARTICLE/BPB/27/5/27_5_706/_PDF", "url": "Biol. Pharm. Bull. 27(5) 706?709 (2004)", "doc_type": "JOURNAL ARTICLE", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "b95e2121-d89b-443a-b1c1-ec0ecb963705", "citation": "EUROPEAN PHARMACOPEDIA ONLINE", "doc_type": "EUROPEAN PHARMACOPEIA", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "5eb258ea-39e8-4689-8b81-04d259813051", "citation": "SRS import [R16CO5Y76E]", "url": "http://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=R16CO5Y76E", "doc_type": "SRS", "public_domain": true, "document_date": 1493389714000, "tags": [ "NOMEN" ] }, { "uuid": "dc38b753-2a77-4359-8b2f-d89f10cd7732", "citation": "ACETYLSALICYLICUM ACIDUM [HPUS]", "doc_type": "SRS_LOCATOR", "public_domain": true }, { "uuid": "021928c7-a306-4c64-8b4d-67924b411770", "citation": "ASPIRIN [USP]", "doc_type": "SRS_LOCATOR", "public_domain": true }, { "uuid": "164ecc00-1619-4fad-9ec4-0b10b6fe1e91", "citation": "ACETYLSALICYLIC ACID [EP]", "doc_type": "SRS_LOCATOR", "public_domain": true }, { "uuid": "cdf3e379-17de-437e-9246-71b18dd5802e", "citation": "ASPIRIN [ORANGE BOOK]", "doc_type": "SRS_LOCATOR", "public_domain": true }, { "uuid": "fa052f29-7e10-4aab-a1b7-abeaaf7d7b12", "citation": "ASPIRIN [MART.]", "doc_type": "SRS_LOCATOR", "public_domain": true }, { "uuid": "642e6dae-ab5f-4331-b46f-36e569a5dd63", "citation": "ASPIRIN [MI]", "doc_type": "SRS_LOCATOR", "public_domain": true }, { "uuid": "e7094fbb-05b7-4bb6-9165-0eefd2e8b1e7", "citation": "ACETYLSALICYLIC ACID [GREEN BOOK]", "doc_type": "SRS_LOCATOR", "public_domain": true }, { "uuid": "92025853-d80d-4081-80ac-196d09e27303", "citation": "ACETYLSALICYLIC ACID [EMA EPAR]", "doc_type": "SRS_LOCATOR", "public_domain": true }, { "uuid": "c0646662-7ba2-480e-98eb-1d7c8c02ce07", "citation": "ACETYLSALICYLIC ACID [INCI]", "doc_type": "SRS_LOCATOR", "public_domain": true }, { "uuid": "d87b9521-c829-4f0c-8f66-101f6f3a67b5", "citation": "ASPIRIN [HSDB]", "doc_type": "SRS_LOCATOR", "public_domain": true }, { "uuid": "81938fb2-747b-471f-a2a4-f82a1e2bf089", "citation": "ASPIRIN [USP-RS]", "doc_type": "SRS_LOCATOR", "public_domain": true }, { "uuid": "09efee30-c1a7-4d61-b4b9-92a52c95a2dd", "citation": "ACETYLSALICYLIC ACID [WHO-DD]", "doc_type": "SRS_LOCATOR", "public_domain": true }, { "uuid": "8ed14aba-d149-49f7-bd9a-aca313488d9c", "citation": "ASPIRIN [VANDF]", "doc_type": "SRS_LOCATOR", "public_domain": true }, { "uuid": "88ce6680-a831-0fad-a42d-92aea8a62f00", "citation": "JAN", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN", "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "f823da75-6cf7-9b20-ab9f-21969eb0691d", "citation": "WEBSITE", "url": "https://toxnet.nlm.nih.gov/cgi-bin/sis/search2/r?dbs+hsdb:@term+@rn+@rel+50-78-2", "doc_type": "WEBSITE", "public_domain": true, "tags": [ "NOMEN", "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "e42d822d-ae63-de9f-7e90-372c4646c77d", "citation": "WEBSITE", "url": "https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=50-78-2", "doc_type": "WEBSITE", "public_domain": true, "tags": [ "NOMEN", "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "4b57ca01-374d-6da4-8084-8b29c1a1db30", "citation": "WEBSITE", "url": "https://toxnet.nlm.nih.gov/cgi-bin/sis/search/r?dbs+lactmed:@term+@rel+@rn+50-78-2", "doc_type": "WEBSITE", "public_domain": true, "tags": [ "NOMEN", "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "928c0335-4c17-0364-8f39-f0ba8cb359f4", "doc_type": "SYSTEM", "public_domain": true }, { "uuid": "c46d623b-70b3-4c50-85ec-79bc9533a268", "citation": "STN", "doc_type": "STN (SCIFINDER)", "public_domain": true }, { "uuid": "fa9b65c6-500c-4207-07d8-a3df2d40bf8e", "citation": "WIKI", "doc_type": "WIKI", "public_domain": true }, { "uuid": "686ec591-11d1-e042-6245-8ba86bc8c181", "citation": "EP 10.5", "doc_type": "EP", "public_domain": true }, { "uuid": "f2b3ab66-0c67-4667-813c-69c65ddedae3", "citation": "EP 10.5", "doc_type": "EP", "public_domain": true, "tags": [ "NOMEN", "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "f52607f4-463b-42ac-b1fa-b26a4c6dad19", "citation": "EP 10.5", "doc_type": "EP", "public_domain": true, "tags": [ "NOMEN", "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "2f0886cc-c72f-471a-bcef-88d60cb0cfde", "citation": "EP 10.5", "doc_type": "EP", "public_domain": true, "tags": [ "NOMEN", "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "7986a67f-46c6-4c77-801d-71e7da8303d0", "citation": "EP 10.5", "doc_type": "EP", "public_domain": true, "tags": [ "NOMEN", "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "01fbbe45-0b5d-4fe9-834e-779f3c6f08b9", "citation": "EP 10.5", "doc_type": "EP", "public_domain": true, "tags": [ "NOMEN", "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "4a880fdb-0a22-4673-b4b4-1c99858bb3b0", "citation": "EP 10.5", "doc_type": "EP", "public_domain": true }, { "uuid": "4ad2103a-b503-a8e9-0fed-fa8174a0f16e", "citation": "USP/NF", "doc_type": "USPNF", "public_domain": true }, { "uuid": "55472576-1b16-bed7-7e3f-670a0f46e820", "citation": "DailyMed", "doc_type": "DAILYMED", "public_domain": true }, { "uuid": "39ac848f-b389-b203-2dd0-815a67ccf0ed", "citation": "NCI", "doc_type": "NCI DRUG DICTIONARY", "public_domain": true }, { "uuid": "80665809-fdec-f6ae-1cea-7ca215c509c1", "citation": "WHO-DD", "doc_type": "WHO DRUG DICTIONARY", "public_domain": true }, { "uuid": "95de6bd3-ac85-e2f7-996d-b5dbf3eca53e", "citation": "EU-SRS", "doc_type": "EMA LIST", "public_domain": true }, { "uuid": "883abf6b-5e77-4116-bf2a-f23ba6adf534", "citation": "Whellan DJ, Goldstein JL, Cryer BL, Eisen GM, Lanas A, Miller AB, Scheiman JM, Fort JG, Zhang Y, O'Connor C. PA32540 (a coordinated-delivery tablet of enteric-coated aspirin 325 mg and immediate-release omeprazole 40 mg) versus enteric-coated aspirin 325 mg alone in subjects at risk for aspirin-associated gastric ulcers: results of two 6-month, phase 3 studies. Am Heart J. 2014 Oct;168(4):495-502.e4. doi: 10.1016/j.ahj.2014.05.017. Epub 2014 Jun 9. PMID: 25262259", "url": "https://pubmed.ncbi.nlm.nih.gov/25262259/", "doc_type": "JA", "public_domain": true }, { "uuid": "c158dafb-4266-4861-b401-c4287559b672", "citation": "An alternative theory on how aspirin may thwart cancer", "url": "https://www.research.va.gov/currents/0217-3.cfm", "doc_type": "WEBSITE", "public_domain": true, "tags": [ "PUBLIC_DOMAIN_RELEASE" ] } ], "definition_type": "PRIMARY", "moieties": [ { "uuid": "a242c635-cafd-43d2-abc7-21c2ebcad5c4", "id": "a242c635-cafd-43d2-abc7-21c2ebcad5c4", "molfile": "\n Marvin 01132108262D \n\n 13 13 0 0 0 0 999 V2000\n 0.7164 -2.4620 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 0.7164 -1.6370 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 0.0000 -1.2362 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0\n 1.4379 -1.2362 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0\n 2.1439 -1.6629 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 2.1439 -2.4620 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 2.8422 -2.9120 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 3.5844 -2.4853 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 3.5844 -1.6629 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 2.8629 -1.2362 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 2.8629 -0.4216 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 3.5637 -0.0155 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0\n 2.1594 0.0000 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0\n 1 2 1 0 0 0 0\n 3 2 2 0 0 0 0\n 2 4 1 0 0 0 0\n 4 5 1 0 0 0 0\n 6 5 1 0 0 0 0\n 5 10 2 0 0 0 0\n 7 6 2 0 0 0 0\n 7 8 1 0 0 0 0\n 8 9 2 0 0 0 0\n 9 10 1 0 0 0 0\n 11 10 1 0 0 0 0\n 12 11 1 0 0 0 0\n 13 11 2 0 0 0 0\nM END", "smiles": "CC(=O)Oc1ccccc1C(=O)O", "formula": "C9H8O4", "atropisomerism": "No", "charge": 0, "count": 1, "stereochemistry": "ACHIRAL", "count_amount": { "type": "MOL RATIO", "average": 1, "units": "MOL RATIO", "uuid": "f43cf4c1-18a1-43ea-b862-c86f0a899153" }, "defined_stereo": 0, "ez_centers": 0, "molecular_weight": "180.1578", "optical_activity": "NONE", "stereo_centers": 0 } ], "definition_level": "COMPLETE", "uuid": "a05ec20c-8fe2-4e02-ba7f-df69e5e30248", "version": "108", "structure": { "id": "4b9639ec-1bb2-4f87-8830-f4f41a862891", "molfile": "\n Marvin 01132103572D \n\n 13 13 0 0 0 0 999 V2000\n 2.8629 -1.2362 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 2.8629 -0.4216 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 2.1439 -1.6629 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 1.4379 -1.2362 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0\n 0.7164 -1.6370 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 3.5637 -0.0155 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0\n 0.0000 -1.2362 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0\n 2.1594 0.0000 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0\n 3.5844 -1.6629 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 2.1439 -2.4620 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 0.7164 -2.4620 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 3.5844 -2.4853 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 2.8422 -2.9120 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 2 1 1 0 0 0 0\n 3 1 2 0 0 0 0\n 4 3 1 0 0 0 0\n 5 4 1 0 0 0 0\n 6 2 2 0 0 0 0\n 7 5 2 0 0 0 0\n 8 2 1 0 0 0 0\n 9 1 1 0 0 0 0\n 10 3 1 0 0 0 0\n 11 5 1 0 0 0 0\n 12 9 2 0 0 0 0\n 13 12 1 0 0 0 0\n 13 10 2 0 0 0 0\nM END", "smiles": "CC(=O)Oc1ccccc1C(=O)O", "formula": "C9H8O4", "atropisomerism": "No", "charge": 0, "count": 1, "stereochemistry": "ACHIRAL", "defined_stereo": 0, "ez_centers": 0, "molecular_weight": "180.1578", "optical_activity": "NONE", "references": [ "5eb258ea-39e8-4689-8b81-04d259813051", "0fedf8bf-9112-4ae7-a876-63aab5fb0ac4" ], "stereo_centers": 0 }, "unii": "R16CO5Y76E", "relationships": [ { "uuid": "ffbc8922-fe67-4f1c-ac10-6c929c3d1129", "amount": { "uuid": "daecc4c3-4715-4341-8803-6350dada4330" }, "type": "SALT/SOLVATE->PARENT", "related_substance": { "uuid": "2b4d9be4-c54d-43b9-909e-0ddd7ce6e85d", "refuuid": "fe031f13-2973-4887-a30e-6edbf48600de", "name": "ALUMINUM ACETYLSALICYLATE", "unii": "ED7L5F608H", "linking_id": "ED7L5F608H", "ref_pname": "ALUMINUM ACETYLSALICYLATE", "substance_class": "reference" } }, { "uuid": "fa478461-0aac-49d8-8a9b-c27f2cd22460", "amount": { "uuid": "d2295e5a-58f1-49c5-8891-f8ff4586653f" }, "type": "ACTIVE MOIETY", "related_substance": { "uuid": "dd2bb2cb-b3de-4ca5-80fe-85131eb6ce2c", "refuuid": "a05ec20c-8fe2-4e02-ba7f-df69e5e30248", "name": "ASPIRIN", "unii": "R16CO5Y76E", "linking_id": "R16CO5Y76E", "ref_pname": "ASPIRIN", "substance_class": "reference" } }, { "uuid": "9e50f96b-72be-4f08-9449-af7e890cf8e6", "amount": { "uuid": "3e8864dc-8cfc-43c1-9c60-ff38a8e92553" }, "type": "SALT/SOLVATE->PARENT", "related_substance": { "uuid": "765f70ed-49dd-4f0c-a6ff-1390d9104467", "refuuid": "66367586-e940-4fad-bec1-526d4c11ac66", "name": "LITHIUM ACETYLSALICYLATE", "unii": "89R59534MK", "linking_id": "89R59534MK", "ref_pname": "LITHIUM ACETYLSALICYLATE", "substance_class": "reference" } }, { "uuid": "93799f37-121d-4c61-bb4c-d61f7d79a888", "type": "SALT/SOLVATE->PARENT", "related_substance": { "uuid": "12456b2a-cdfc-4911-974a-3cbf2cada3aa", "refuuid": "39305c46-e2bd-4343-bdd3-8502874c9f1e", "name": "ASPIRIN ALUMINUM", "unii": "E33TS05V6B", "linking_id": "E33TS05V6B", "ref_pname": "ASPIRIN ALUMINUM", "substance_class": "reference" } }, { "uuid": "1ba63f2a-074c-4f18-8d3d-d0fd3caced3e", "type": "SALT/SOLVATE->PARENT", "related_substance": { "uuid": "ee16aabc-5f0b-4fcb-9fbe-e05cdd5f418d", "refuuid": "8919c8de-dccd-4d97-a4bc-82cd34a0616b", "name": "ASPIRIN CALCIUM", "unii": "WOD7W0DGZS", "linking_id": "WOD7W0DGZS", "ref_pname": "ASPIRIN CALCIUM", "substance_class": "reference" } }, { "uuid": "cd53bab5-9366-49f0-9902-6e3aaa604d03", "type": "SALT/SOLVATE->PARENT", "related_substance": { "uuid": "8b2d3ba0-39f0-48e5-a430-61f5f0f9426b", "refuuid": "ddd4b3a1-709d-4052-9710-6d805767d4bf", "name": "ASPIRIN GLYCINE CALCIUM", "unii": "NK259942HJ", "linking_id": "NK259942HJ", "ref_pname": "ASPIRIN GLYCINE CALCIUM", "substance_class": "reference" } }, { "uuid": "6ed72025-0efb-4fc4-a677-03cb58b26096", "type": "SALT/SOLVATE->PARENT", "related_substance": { "uuid": "2f434fef-480f-4db6-a573-838d0abee3c5", "refuuid": "f10e9236-3789-4d8a-9dca-bf3fe4c9627b", "name": "ASPIRIN LYSINE", "unii": "XAN4V337CI", "linking_id": "XAN4V337CI", "ref_pname": "ASPIRIN LYSINE", "substance_class": "reference" } }, { "uuid": "7edb18ef-8c56-43ef-9923-3de3760499bc", "type": "SALT/SOLVATE->PARENT", "related_substance": { "uuid": "13a6bb29-fdd7-4745-95ba-14a00869e70a", "refuuid": "75e43f39-ee3b-41ca-b6d6-4667dec7b032", "name": "ASPIRIN MAGNESIUM", "unii": "4995924SMK", "linking_id": "4995924SMK", "ref_pname": "ASPIRIN MAGNESIUM", "substance_class": "reference" } }, { "uuid": "966d9712-fe46-45d7-b108-d0ba5a48552e", "type": "SALT/SOLVATE->PARENT", "related_substance": { "uuid": "8a7564e7-8559-4371-8286-985cb7bdbca8", "refuuid": "a85a4806-5c67-4e14-a22d-b8f949167e34", "name": "ASPIRIN SODIUM", "unii": "E62HT5S2E9", "linking_id": "E62HT5S2E9", "ref_pname": "ASPIRIN SODIUM", "substance_class": "reference" } }, { "uuid": "34bd672f-8aef-485d-81a4-5c20a046c428", "type": "SALT/SOLVATE->PARENT", "related_substance": { "uuid": "966e473f-cd07-4d8b-bbdf-1f487a08b410", "refuuid": "b929da66-df59-487b-a5d5-0354a07c1a0f", "name": "ASPIRIN COPPER", "unii": "5DR11472UI", "linking_id": "5DR11472UI", "ref_pname": "ASPIRIN COPPER", "substance_class": "reference" } }, { "uuid": "4fc11b26-641d-4122-b913-2c35de1589de", "type": "SALT/SOLVATE->PARENT", "related_substance": { "uuid": "5da9187d-7f01-4ed9-90a2-f1e6cb80ebda", "refuuid": "c082475a-3be4-4bdf-9104-e58d45821aa0", "name": "ALOXIPRIN", "unii": "6QT214X4XU", "linking_id": "6QT214X4XU", "ref_pname": "ALOXIPRIN", "substance_class": "reference" } }, { "uuid": "af186514-3009-4d3a-a3ad-299d0faad023", "type": "SALT/SOLVATE->PARENT", "related_substance": { "uuid": "61351ddb-87dc-4525-8558-4c1de35dc6eb", "refuuid": "eeb57cb9-3671-4111-9afd-3a43fb3727c0", "name": "CARBASPIRIN", "unii": "73J0P7720Y", "linking_id": "73J0P7720Y", "ref_pname": "CARBASPIRIN", "substance_class": "reference" } }, { "uuid": "6b77faff-7bf5-47ce-bdf2-8b14cb39c73f", "type": "SALT/SOLVATE->PARENT", "related_substance": { "uuid": "f696be60-5a64-4787-ac85-49ac49552c19", "refuuid": "405731a7-1fcb-43f0-acb1-b7843f6e88df", "name": "CARBASPIRIN CALCIUM", "unii": "N667F17JP1", "linking_id": "N667F17JP1", "ref_pname": "CARBASPIRIN CALCIUM", "substance_class": "reference" } }, { "uuid": "b0ddbc68-a8c5-4668-92e3-152283bd2f8d", "amount": { "uuid": "eaf8dad8-98f4-4279-940d-54e8c60b9b3e", "type": "RELATIONSHIP_AMOUNT", "units": "MOLE PERCENT OF AMOUNT EXCRETED", "high_limit": 70, "low_limit": 30 }, "qualification": "URINE", "type": "METABOLITE INACTIVE->PARENT", "interaction_type": "MAJOR", "references": [ "3b38330d-93b5-4c7c-bf99-1032b869c1db" ], "related_substance": { "uuid": "377a16e4-45d6-44ef-b285-c1968dae09d0", "refuuid": "c2cf606e-9a47-4b3e-9c01-ec56a7378742", "name": "N-SALICYLOYLGLYCINE", "unii": "5BR3P7J05U", "linking_id": "5BR3P7J05U", "ref_pname": "N-SALICYLOYLGLYCINE", "substance_class": "reference" } }, { "uuid": "386440ce-e3de-4a99-8dd4-55f7ab93be3d", "amount": { "uuid": "1f5b370b-a753-4f94-9df9-1f18009c7115", "type": "RELATIONSHIP_AMOUNT", "high_limit": 30, "low_limit": 5 }, "qualification": "URINE", "type": "METABOLITE->PARENT", "interaction_type": "MAJOR", "references": [ "3b38330d-93b5-4c7c-bf99-1032b869c1db" ], "related_substance": { "uuid": "63cabcf8-68fe-4275-b252-75fa992b59d0", "refuuid": "b0201685-7e19-4c8a-a3cf-3e04505e02e5", "name": "GENTISIC ACID", "unii": "VP36V95O3T", "linking_id": "VP36V95O3T", "ref_pname": "GENTISIC ACID", "substance_class": "reference" } }, { "uuid": "45c03733-34e4-441c-9785-3cccd0c876c0", "amount": { "uuid": "051a8cf2-62c6-4125-a99e-32e6af0971e7", "type": "RELATIONSHIP_AMOUNT", "high_limit": 10, "low_limit": 3 }, "qualification": "URINE", "type": "METABOLITE ACTIVE->PARENT", "interaction_type": "MINOR", "references": [ "f99118ca-88f6-407e-83b0-90e5770b2c0a" ], "related_substance": { "uuid": "ed604ad8-9d93-477f-a645-16f35fa47058", "refuuid": "77ecc185-155e-4f2d-8b74-81c91be840d2", "name": "Salicylic acid", "unii": "O414PZ4LPZ", "linking_id": "O414PZ4LPZ", "ref_pname": "Salicylic acid", "substance_class": "reference" } }, { "uuid": "9b291694-1ccd-4eba-a652-e71d627a6d44", "amount": { "uuid": "cedba0d8-2ff1-4013-adbd-b59d0af200af", "units": "PERCENT PEAK AREA", "high_limit": 0.15 }, "qualification": "EP", "type": "IMPURITY->PARENT", "interaction_type": "CHROMATOGRAPHIC PURITY (HPLC/UV)", "references": [ "f52607f4-463b-42ac-b1fa-b26a4c6dad19" ], "related_substance": { "uuid": "00ec0474-7405-4864-b389-faa86c3e63a5", "refuuid": "beb8e4b3-5011-4f42-9cce-271456343519", "name": "4-Hydroxybenzoic Acid", "unii": "JG8Z55Y12H", "linking_id": "JG8Z55Y12H", "ref_pname": "4-Hydroxybenzoic Acid", "substance_class": "reference" } }, { "uuid": "46728ac3-5398-432a-9136-b1adfdedf297", "amount": { "uuid": "50b46809-c685-4932-a230-88d3fc5f0494", "units": "PERCENT PEAK AREA", "high_limit": 0.15 }, "qualification": "EP", "type": "IMPURITY->PARENT", "interaction_type": "CHROMATOGRAPHIC PURITY (HPLC/UV)", "references": [ "01fbbe45-0b5d-4fe9-834e-779f3c6f08b9" ], "related_substance": { "uuid": "7522b7d4-fdd0-4357-966e-7222e91c71b4", "refuuid": "0b8cdd85-6608-4bf3-b443-f79209a3a284", "name": "4-Hydroxyisophthalic acid", "unii": "P87FF77O00", "linking_id": "P87FF77O00", "ref_pname": "4-Hydroxyisophthalic acid", "substance_class": "reference" } }, { "uuid": "37021f40-6758-40d1-84e6-722ef6197df0", "amount": { "uuid": "ab4f7c71-11ab-4064-bff8-799b3ff481ce", "units": "PERCENT PEAK AREA", "high_limit": 0.15 }, "qualification": "EP", "type": "IMPURITY->PARENT", "interaction_type": "CHROMATOGRAPHIC PURITY (HPLC/UV)", "references": [ "4a880fdb-0a22-4673-b4b4-1c99858bb3b0" ], "related_substance": { "uuid": "252d7e9c-9f52-48c7-8577-c6868fad003c", "refuuid": "77ecc185-155e-4f2d-8b74-81c91be840d2", "name": "Salicylic acid", "unii": "O414PZ4LPZ", "linking_id": "O414PZ4LPZ", "ref_pname": "Salicylic acid", "substance_class": "reference" } }, { "uuid": "b15e003f-bc4f-4b90-bff1-c2ef163f687c", "amount": { "uuid": "2fae90ae-a780-4ed2-8325-955efebcc3f9", "units": "PERCENT PEAK AREA", "high_limit": 0.15 }, "qualification": "EP", "type": "IMPURITY->PARENT", "interaction_type": "CHROMATOGRAPHIC PURITY (HPLC/UV)", "references": [ "f2b3ab66-0c67-4667-813c-69c65ddedae3" ], "related_substance": { "uuid": "541c457c-366f-4869-969e-739c938c648c", "refuuid": "8657e9d9-7e84-4797-aa45-362ac12b8e33", "name": "ACETYLSALICYLSALICYLIC ACID", "unii": "VBE72MCP5L", "linking_id": "VBE72MCP5L", "ref_pname": "ACETYLSALICYLSALICYLIC ACID", "substance_class": "reference" } }, { "uuid": "061f2321-16f5-4775-ba57-ffa028e65ad9", "amount": { "uuid": "7f2ea38e-ac81-4a2b-bed2-281d01534fcb", "type": "WEIGHT PERCENT", "units": "%", "high_limit": 0.15, "non_numeric_value": "peak area" }, "comments": "IDENTIFIED AS IMPURITY E\nLimits: impurity E: not more than 1.5 times the area of the principal peak in the chromatogram obtained with reference solution (a) (0.15 per cent)Herbal Medicines 4th ED 2103", "qualification": "EP", "type": "IMPURITY->PARENT", "interaction_type": "CHROMATOGRAPHIC PURITY (HPLC/UV)", "references": [ "b95e2121-d89b-443a-b1c1-ec0ecb963705" ], "related_substance": { "uuid": "25d1c7e3-f0e7-49f2-8e37-7bbf71e5c6f6", "refuuid": "4b40bd34-96c2-4b98-b9b9-5063d6397406", "name": "SALSALATE", "unii": "V9MO595C9I", "linking_id": "V9MO595C9I", "ref_pname": "SALSALATE", "substance_class": "reference" } }, { "uuid": "2d1f9be9-decf-4745-a86d-f23df91c32b3", "comments": "IDENTIFIED AS IMPURITY A\nLimits: impurity A: not more than 1.5 times the area of the principal peak in the chromatogram obtained with reference solution (a) (0.15 per cent)", "type": "IMPURITY->PARENT", "references": [ "b95e2121-d89b-443a-b1c1-ec0ecb963705" ], "related_substance": { "uuid": "81482302-f2bf-47f3-98d2-b4c61fed3205", "refuuid": "beb8e4b3-5011-4f42-9cce-271456343519", "name": "4-Hydroxybenzoic Acid", "unii": "JG8Z55Y12H", "linking_id": "JG8Z55Y12H", "ref_pname": "4-Hydroxybenzoic Acid", "substance_class": "reference" } }, { "uuid": "d105983c-ffe0-4f07-8834-6890b4a03ef3", "comments": "IDENTIFIED AS IMPURITY B\nLimits: impurity B: not more than 1.5 times the area of the principal peak in the chromatogram obtained with reference solution (a) (0.15 per cent)", "type": "IMPURITY->PARENT", "references": [ "b95e2121-d89b-443a-b1c1-ec0ecb963705" ], "related_substance": { "uuid": "e8d79863-f6eb-43c8-80c3-ffebcc5cfcfb", "refuuid": "0b8cdd85-6608-4bf3-b443-f79209a3a284", "name": "4-Hydroxyisophthalic acid", "unii": "P87FF77O00", "linking_id": "P87FF77O00", "ref_pname": "4-Hydroxyisophthalic acid", "substance_class": "reference" } }, { "uuid": "7246ec31-9e0c-42fd-91cf-439d6aecdea7", "amount": { "uuid": "276e376e-60dc-461b-97fc-fbb9ed003dff", "type": "WEIGHT PERCENT", "average": 0.2, "units": "%" }, "qualification": "INTERNATIONAL PHARMACOPEIA", "type": "IMPURITY->PARENT", "interaction_type": "ASSAY (COLORIMETRIC)", "references": [ "b95e2121-d89b-443a-b1c1-ec0ecb963705" ], "related_substance": { "uuid": "d65920f7-9191-43b6-9e81-c946aff1bf62", "refuuid": "77ecc185-155e-4f2d-8b74-81c91be840d2", "name": "Salicylic acid", "unii": "O414PZ4LPZ", "linking_id": "O414PZ4LPZ", "ref_pname": "Salicylic acid", "substance_class": "reference" } }, { "uuid": "b3021de4-f9b7-4c14-b226-c7a994818aca", "amount": { "uuid": "27667d03-c328-4b20-af0e-b6d5228f3680", "units": "PERCENT PEAK AREA", "high_limit": 0.15 }, "qualification": "EP", "type": "IMPURITY->PARENT", "interaction_type": "CHROMATOGRAPHIC PURITY (HPLC/UV)", "references": [ "2f0886cc-c72f-471a-bcef-88d60cb0cfde" ], "related_substance": { "uuid": "d63652e8-1199-4b71-9f6c-a606853ebeaa", "refuuid": "4b40bd34-96c2-4b98-b9b9-5063d6397406", "name": "SALSALATE", "unii": "V9MO595C9I", "linking_id": "V9MO595C9I", "ref_pname": "SALSALATE", "substance_class": "reference" } }, { "uuid": "66bd2d74-8cc0-40ec-8fe6-81cc94838207", "amount": { "uuid": "7438295e-0a2c-44fc-b3e6-280d0f8e47fd", "units": "PERCENT PEAK AREA", "high_limit": 0.15 }, "qualification": "EP", "type": "IMPURITY->PARENT", "interaction_type": "CHROMATOGRAPHIC PURITY (HPLC/UV)", "references": [ "7986a67f-46c6-4c77-801d-71e7da8303d0" ], "related_substance": { "uuid": "56e8cc65-e72d-45f0-b9d7-bd63094519f8", "refuuid": "b01ae0ed-0de4-471a-aca5-7902f31b05ab", "name": "ASPIRIN ANHYDRIDE", "unii": "XIA5Z82RHB", "linking_id": "XIA5Z82RHB", "ref_pname": "ASPIRIN ANHYDRIDE", "substance_class": "reference" } }, { "uuid": "e22257bb-3dfd-4c74-95e0-a8a182c8c707", "amount": { "uuid": "daff2c1a-f3ea-4c57-bc1b-e8e7d9c9a36a" }, "type": "SALT/SOLVATE->PARENT", "related_substance": { "uuid": "a75b8b30-fa45-4e43-bd8c-e669534a00b9", "refuuid": "afff7b65-3b68-4cbc-afab-17ee49e05740", "name": "ZINC ASPIRIN", "unii": "8649Y4P3PA", "linking_id": "8649Y4P3PA", "ref_pname": "ZINC ASPIRIN", "substance_class": "reference" } }, { "uuid": "cfe81cef-f6b9-48c7-9bf0-af69c3a6ccaa", "amount": { "uuid": "bc488f0a-9b07-443b-8370-75b263845de0" }, "type": "PRODRUG->METABOLITE ACTIVE", "related_substance": { "uuid": "3c9d06e6-9c6c-4b75-b7c6-3507831a42cf", "refuuid": "b5115322-7edc-481a-b85c-a4b8d115b325", "name": "Aspirin Trelamine", "unii": "JKW59XM343", "linking_id": "JKW59XM343", "ref_pname": "Aspirin Trelamine" } }, { "uuid": "4c53d776-b9db-4d0c-ac04-dd5b98cc4d6b", "amount": { "uuid": "ab674772-df93-4dd3-b56a-37d98cd3602f" }, "type": "IMPURITY->PARENT", "related_substance": { "uuid": "0d6baabd-76fc-463c-8409-bc0126a0cf89", "refuuid": "908ace0c-0dc9-42da-a18e-57fa2d2f5e22", "name": "Tambjamine F", "unii": "NNX3NPN9FX", "linking_id": "NNX3NPN9FX", "ref_pname": "Tambjamine F", "substance_class": "reference" } } ], "names": [ { "uuid": "c7069333-892e-4828-97aa-6ea06434cb34", "name": "2-(ACETYLOXY)BENZOIC ACID", "stdName": "2-(ACETYLOXY)BENZOIC ACID", "type": "sys", "languages": [ "en" ], "preferred": false, "references": [ "b795c9a5-b1e7-4092-9e4e-d167d97e73ef" ], "display_name": false }, { "uuid": "19144a23-5c43-4ad2-b894-761915330349", "name": "2-ACETYLOXYBENZOIC ACID", "stdName": "2-ACETYLOXYBENZOIC ACID", "type": "sys", "languages": [ "en" ], "preferred": false, "references": [ "919c5a16-f3ac-4b69-8379-603f07c4d74e" ], "display_name": false }, { "uuid": "17796a92-7d19-41dd-8a1d-85f7fc2602ac", "name": "ACETYL SALICYLATE", "stdName": "ACETYL SALICYLATE", "type": "sys", "languages": [ "en" ], "preferred": false, "references": [ "b3548777-047f-44d3-9c55-4909a0fde423" ], "display_name": false }, { "uuid": "c5121134-4cd0-40ce-8d68-160951300713", "name": "ACETYLSALICYLIC ACID", "stdName": "ACETYLSALICYLIC ACID", "type": "of", "languages": [ "en" ], "preferred": true, "references": [ "fda2dc61-1264-40af-8758-3390e4d60ad6", "92025853-d80d-4081-80ac-196d09e27303", "164ecc00-1619-4fad-9ec4-0b10b6fe1e91", "dd19a315-71b2-45a2-a337-5c64b26e4586", "09efee30-c1a7-4d61-b4b9-92a52c95a2dd", "b795c9a5-b1e7-4092-9e4e-d167d97e73ef", "b3e56dca-af76-4b98-a9b4-243cc1bf6eb6", "e7094fbb-05b7-4bb6-9165-0eefd2e8b1e7", "18815669-0ccb-4d9f-b665-41bd6a024220", "d64e9fda-15d4-440e-b9b4-eaaeb6d61dd7", "c0646662-7ba2-480e-98eb-1d7c8c02ce07" ], "display_name": false, "domains": [ "cosmetic" ], "name_orgs": [ { "uuid": "42570ec2-eb91-4775-980c-4ef40bf90108", "name_org": "INCI" } ] }, { "uuid": "48d89039-025b-4fe5-bd9a-c9a876c49ae6", "name": "ACETYLSALICYLIC ACID (WHO-IP)", "stdName": "ACETYLSALICYLIC ACID (WHO-IP)", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "a9fd4df5-0685-47c5-8cae-52b7564e7d54" ], "display_name": false }, { "uuid": "31071e18-01f5-4fb8-9c99-336e1b4883e7", "name": "ACETYLSALICYLIC ACID [EMA EPAR]", "stdName": "ACETYLSALICYLIC ACID [EMA EPAR]", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "dd19a315-71b2-45a2-a337-5c64b26e4586" ], "display_name": false }, { "uuid": "b194b099-c318-53f0-a97e-83f3a4bdadb7", "name": "ACETYLSALICYLIC ACID [EP MONOGRAPH]", "stdName": "ACETYLSALICYLIC ACID [EP MONOGRAPH]", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "686ec591-11d1-e042-6245-8ba86bc8c181" ], "display_name": false }, { "uuid": "46b26be6-4030-41db-ae23-cb02780f1ee2", "name": "ACETYLSALICYLIC ACID [GREEN BOOK]", "stdName": "ACETYLSALICYLIC ACID [GREEN BOOK]", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "b3e56dca-af76-4b98-a9b4-243cc1bf6eb6" ], "display_name": false }, { "uuid": "dce81d96-2361-4335-9b6e-fc20ba102ade", "name": "ACETYLSALICYLICUM ACIDUM", "stdName": "ACETYLSALICYLICUM ACIDUM", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "dc38b753-2a77-4359-8b2f-d89f10cd7732", "d80b788d-5afd-46c9-b8d8-5fad1dd7d946", "2cfd4ae8-b563-4eb8-8583-d161bd6a6889", "7c51c2b1-c5f9-4c91-a806-69d7f24a4570" ], "display_name": false }, { "uuid": "bdb98c87-6e03-462b-83b9-e5d01366c685", "name": "ACETYLSALICYLICUM ACIDUM [HPUS]", "stdName": "ACETYLSALICYLICUM ACIDUM [HPUS]", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "d80b788d-5afd-46c9-b8d8-5fad1dd7d946", "2cfd4ae8-b563-4eb8-8583-d161bd6a6889" ], "display_name": false }, { "uuid": "941cac81-2eb6-4aa2-aa9c-306426d330b6", "name": "ACIDUM ACETYLSALICYLICUM", "stdName": "ACIDUM ACETYLSALICYLICUM", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "b795c9a5-b1e7-4092-9e4e-d167d97e73ef" ], "display_name": false }, { "uuid": "6a5876f1-dda9-446b-babd-0c921a3e3bdc", "name": "ACIDUM ACETYLSALICYLICUM (WHO-IP)", "stdName": "ACIDUM ACETYLSALICYLICUM (WHO-IP)", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "a9fd4df5-0685-47c5-8cae-52b7564e7d54" ], "display_name": false }, { "uuid": "383cbe38-0335-4ebf-8371-77fb4c65e37d", "name": "AGGRENOX COMPONENT ASPIRIN", "stdName": "AGGRENOX COMPONENT ASPIRIN", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "46e82f2b-8ec5-4d3a-8039-62ba0f7ab34d", "5aa6dab6-399a-42e6-842f-e6f848c7b832" ], "display_name": false }, { "uuid": "2361dffc-4786-4180-8cb0-abaf156cd427", "name": "ASA", "stdName": "ASA", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "46a42348-c88b-408d-b596-a27280aff449" ], "display_name": false }, { "uuid": "069c37f0-4a19-4c8f-ad34-196556bb5037", "name": "ASPIRIN", "stdName": "ASPIRIN", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "a2bacf49-c3ab-42b1-948e-4caf9d13dcc6", "c2c31c52-cf50-477b-b020-aa85b4cfc4d4", "d87b9521-c829-4f0c-8f66-101f6f3a67b5", "fa052f29-7e10-4aab-a1b7-abeaaf7d7b12", "81938fb2-747b-471f-a2a4-f82a1e2bf089", "6b443371-95be-47a4-901e-9c314a8fb5db", "747bac63-454a-481c-b7e2-6f6db0bee5c9", "0fedf8bf-9112-4ae7-a876-63aab5fb0ac4", "642e6dae-ab5f-4331-b46f-36e569a5dd63", "c814e853-bd01-4f1f-b23a-38686fbf7c90", "cdf3e379-17de-437e-9246-71b18dd5802e", "021928c7-a306-4c64-8b4d-67924b411770", "3f43d255-788b-4df8-b924-cc25dfedb171", "098f0f09-2036-4008-a870-f473a32fc45b", "8ed14aba-d149-49f7-bd9a-aca313488d9c" ], "display_name": true }, { "uuid": "be80c144-b8a4-4ad6-87e2-10f7f3553f4c", "name": "ASPIRIN [HSDB]", "stdName": "ASPIRIN [HSDB]", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "3f43d255-788b-4df8-b924-cc25dfedb171" ], "display_name": false }, { "uuid": "83a35db3-f9c1-44c2-8958-e49faa20bd65", "name": "ASPIRIN [JAN]", "stdName": "ASPIRIN [JAN]", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "88ce6680-a831-0fad-a42d-92aea8a62f00" ], "display_name": false }, { "uuid": "52345a18-e066-4f91-94ee-35a10881c2db", "name": "ASPIRIN [MART.]", "stdName": "ASPIRIN [MART.]", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "747bac63-454a-481c-b7e2-6f6db0bee5c9" ], "display_name": false }, { "uuid": "d4e48596-b40d-45ba-b9ad-f0080a3d7fc7", "name": "ASPIRIN [MI]", "stdName": "ASPIRIN [MI]", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "a2bacf49-c3ab-42b1-948e-4caf9d13dcc6" ], "display_name": false }, { "uuid": "1954eb62-e60a-4ea9-a0d5-65f9a7651d7c", "name": "ASPIRIN [ORANGE BOOK]", "stdName": "ASPIRIN [ORANGE BOOK]", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "c814e853-bd01-4f1f-b23a-38686fbf7c90" ], "display_name": false }, { "uuid": "235f47b5-fb2b-d996-870f-1d3de6784f40", "name": "ASPIRIN [USP MONOGRAPH]", "stdName": "ASPIRIN [USP MONOGRAPH]", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "4ad2103a-b503-a8e9-0fed-fa8174a0f16e" ], "display_name": false }, { "uuid": "8866741c-8a7a-446a-b127-b5919e78c09e", "name": "ASPIRIN [USP-RS]", "stdName": "ASPIRIN [USP-RS]", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "098f0f09-2036-4008-a870-f473a32fc45b" ], "display_name": false }, { "uuid": "6084ad47-33ad-4b21-a522-da3ee583a7ef", "name": "ASPIRIN [VANDF]", "stdName": "ASPIRIN [VANDF]", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "c2c31c52-cf50-477b-b020-aa85b4cfc4d4" ], "display_name": false }, { "uuid": "6e3fc596-0dcc-42d6-93b8-52f21d8b3840", "name": "AXOTAL COMPONENT ASPIRIN", "stdName": "AXOTAL COMPONENT ASPIRIN", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "46e82f2b-8ec5-4d3a-8039-62ba0f7ab34d", "5aa6dab6-399a-42e6-842f-e6f848c7b832" ], "display_name": false }, { "uuid": "aee32803-50f2-41c3-abe4-509ff83c63cb", "name": "AZDONE COMPONENT ASPIRIN", "stdName": "AZDONE COMPONENT ASPIRIN", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "46e82f2b-8ec5-4d3a-8039-62ba0f7ab34d", "5aa6dab6-399a-42e6-842f-e6f848c7b832" ], "display_name": false }, { "uuid": "9f2cb8d6-a265-4c8d-b5fe-3c0bd117a232", "name": "Acetylsalicylic acid [WHO-DD]", "stdName": "ACETYLSALICYLIC ACID [WHO-DD]", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "80665809-fdec-f6ae-1cea-7ca215c509c1" ], "display_name": false }, { "uuid": "21b60b15-16d5-4780-b282-cfe70a3e15c7", "name": "Aspirin-PC component aspirin", "stdName": "ASPIRIN-PC COMPONENT ASPIRIN", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "c158dafb-4266-4861-b401-c4287559b672" ], "display_name": false }, { "uuid": "1fd504db-8224-42f7-8086-3fbb9b7dec80", "name": "BAY1019036", "stdName": "BAY1019036", "type": "cd", "languages": [ "en" ], "preferred": false, "references": [ "8a6afa6e-1bdb-4b33-b673-a1e239123a0e" ], "display_name": false }, { "uuid": "8ba58215-882e-4afb-9c1b-9b485cb12f71", "name": "BENZOIC ACID, 2-(ACETYLOXY)-", "stdName": "BENZOIC ACID, 2-(ACETYLOXY)-", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "9bff8ba8-0ef5-4c4d-97de-48ec020106b7" ], "display_name": false }, { "uuid": "98e5cc5b-2d1d-487e-995d-1432854e1f30", "name": "CARISOPRODOL COMPOUND COMPONENT ASPIRIN", "stdName": "CARISOPRODOL COMPOUND COMPONENT ASPIRIN", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "46e82f2b-8ec5-4d3a-8039-62ba0f7ab34d", "5aa6dab6-399a-42e6-842f-e6f848c7b832" ], "display_name": false }, { "uuid": "074b6229-be0f-4e2e-b610-f8c6b4031ad0", "name": "CLOPIDOGREL/ACETYLSALICYLIC ACID COMPONENT ASPIRIN", "stdName": "CLOPIDOGREL/ACETYLSALICYLIC ACID COMPONENT ASPIRIN", "type": "bn", "languages": [ "en" ], "preferred": false, "references": [ "5ec89d1e-64a6-4148-8801-b5c0b4ad39fa" ], "display_name": false }, { "uuid": "39277189-cb13-4597-b54a-8f27df05d08c", "name": "CODOXY COMPONENT ASPIRIN", "stdName": "CODOXY COMPONENT ASPIRIN", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "46e82f2b-8ec5-4d3a-8039-62ba0f7ab34d", "5aa6dab6-399a-42e6-842f-e6f848c7b832" ], "display_name": false }, { "uuid": "696dbcf8-e17a-4d37-9db8-bd3dc304881c", "name": "DARVON COMPOUND COMPONENT ASPIRIN", "stdName": "DARVON COMPOUND COMPONENT ASPIRIN", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "46e82f2b-8ec5-4d3a-8039-62ba0f7ab34d", "5aa6dab6-399a-42e6-842f-e6f848c7b832" ], "display_name": false }, { "uuid": "11514aae-94db-4099-8480-8814c8f4ea11", "name": "DUOCOVER COMPONENT ASPIRIN", "stdName": "DUOCOVER COMPONENT ASPIRIN", "type": "bn", "languages": [ "en" ], "preferred": false, "references": [ "64d12b0f-0d9d-4896-8770-b827ea3128ff" ], "display_name": false }, { "uuid": "21e0df61-b81e-4ce8-be64-9100d953598f", "name": "DUOPLAVIN COMPONENT ASPIRIN", "stdName": "DUOPLAVIN COMPONENT ASPIRIN", "type": "bn", "languages": [ "en" ], "preferred": false, "references": [ "d059d77b-1f6c-4c77-9d67-7fa1c56deac5" ], "display_name": false }, { "uuid": "f7fa615e-43cd-4d6a-ab08-872dcab15553", "name": "DURLAZA", "stdName": "DURLAZA", "type": "bn", "languages": [ "en" ], "preferred": false, "references": [ "7da2f850-3e18-4d09-92c2-128028795de0" ], "display_name": false }, { "uuid": "cbd1b931-0d16-4c7c-b5fb-0318f7452b1f", "name": "EQUAGESIC COMPONENT ASPIRIN", "stdName": "EQUAGESIC COMPONENT ASPIRIN", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "46e82f2b-8ec5-4d3a-8039-62ba0f7ab34d", "5aa6dab6-399a-42e6-842f-e6f848c7b832" ], "display_name": false }, { "uuid": "b30ef17e-b9ac-4881-bedb-31e1b2d2a876", "name": "EXCEDRIN COMPONENT ASPIRIN", "stdName": "EXCEDRIN COMPONENT ASPIRIN", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "46e82f2b-8ec5-4d3a-8039-62ba0f7ab34d", "5aa6dab6-399a-42e6-842f-e6f848c7b832" ], "display_name": false }, { "uuid": "9049ca17-8a15-4614-aecc-bfd453c033b3", "name": "FIORINAL COMPONENT ASPIRIN", "stdName": "FIORINAL COMPONENT ASPIRIN", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "46e82f2b-8ec5-4d3a-8039-62ba0f7ab34d", "5aa6dab6-399a-42e6-842f-e6f848c7b832" ], "display_name": false }, { "uuid": "6fa468a1-2d88-4c9e-a63d-429a2943605b", "name": "INVAGESIC COMPONENT ASPIRIN", "stdName": "INVAGESIC COMPONENT ASPIRIN", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "46e82f2b-8ec5-4d3a-8039-62ba0f7ab34d", "5aa6dab6-399a-42e6-842f-e6f848c7b832" ], "display_name": false }, { "uuid": "21ccf269-35c1-41e1-8c36-8f22bcac05ae", "name": "INVAGESIC FORTE COMPONENT ASPIRIN", "stdName": "INVAGESIC FORTE COMPONENT ASPIRIN", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "46e82f2b-8ec5-4d3a-8039-62ba0f7ab34d", "5aa6dab6-399a-42e6-842f-e6f848c7b832" ], "display_name": false }, { "uuid": "7f98aa99-702a-4581-8d41-ced08a5a4de7", "name": "LANORINAL COMPONENT ASPIRIN", "stdName": "LANORINAL COMPONENT ASPIRIN", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "46e82f2b-8ec5-4d3a-8039-62ba0f7ab34d", "5aa6dab6-399a-42e6-842f-e6f848c7b832" ], "display_name": false }, { "uuid": "3a028eea-c8a8-45f3-ab46-7cfc936a551c", "name": "MEASURIN", "stdName": "MEASURIN", "type": "bn", "languages": [ "en" ], "preferred": false, "references": [ "f4dfdbd4-ea02-4b6b-a6ff-22ab95cb9bed" ], "display_name": false }, { "uuid": "56718bee-ec8d-44c2-a3db-d8e61d45de1a", "name": "MEPRO-ASPIRIN COMPONENT ASPIRIN", "stdName": "MEPRO-ASPIRIN COMPONENT ASPIRIN", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "46e82f2b-8ec5-4d3a-8039-62ba0f7ab34d", "5aa6dab6-399a-42e6-842f-e6f848c7b832" ], "display_name": false }, { "uuid": "77c83fe2-bb6c-4d26-abf7-8fe701ee5347", "name": "MICRAININ COMPONENT ASPIRIN", "stdName": "MICRAININ COMPONENT ASPIRIN", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "46e82f2b-8ec5-4d3a-8039-62ba0f7ab34d", "5aa6dab6-399a-42e6-842f-e6f848c7b832" ], "display_name": false }, { "uuid": "4a5fab9a-a792-4c2a-bcd5-0adf341d684c", "name": "NORGESIC COMPONENT ASPIRIN", "stdName": "NORGESIC COMPONENT ASPIRIN", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "46e82f2b-8ec5-4d3a-8039-62ba0f7ab34d", "5aa6dab6-399a-42e6-842f-e6f848c7b832" ], "display_name": false }, { "uuid": "31293f9d-366d-4569-b1df-a40be9f6c8b2", "name": "NSC-27223", "stdName": "NSC-27223", "type": "cd", "languages": [ "en" ], "preferred": false, "references": [ "6e4e22a6-0d29-4532-960e-9d99bda9fad8" ], "display_name": false }, { "uuid": "8981c0fd-dabd-493a-b5a0-1f5a3eb5efab", "name": "NSC-406186", "stdName": "NSC-406186", "type": "cd", "languages": [ "en" ], "preferred": false, "references": [ "6e4e22a6-0d29-4532-960e-9d99bda9fad8" ], "display_name": false }, { "uuid": "6313fcf6-155b-4f56-8ced-8cc5023bd6fd", "name": "ORPHENGESIC COMPONENT ASPIRIN", "stdName": "ORPHENGESIC COMPONENT ASPIRIN", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "46e82f2b-8ec5-4d3a-8039-62ba0f7ab34d", "5aa6dab6-399a-42e6-842f-e6f848c7b832" ], "display_name": false }, { "uuid": "d7aa7807-2bdb-443d-bfc0-d04b14ee35f3", "name": "ORPHENGESIC FORTE COMPONENT ASPIRIN", "stdName": "ORPHENGESIC FORTE COMPONENT ASPIRIN", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "46e82f2b-8ec5-4d3a-8039-62ba0f7ab34d", "5aa6dab6-399a-42e6-842f-e6f848c7b832" ], "display_name": false }, { "uuid": "9eb51ab4-b0d7-468a-82cb-192e49e24fd2", "name": "PA-32540 component aspirin", "stdName": "PA-32540 COMPONENT ASPIRIN", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "883abf6b-5e77-4116-bf2a-f23ba6adf534" ], "display_name": false }, { "uuid": "cd065890-0ac3-416b-8bba-064671a8abbd", "name": "PERCODAN COMPONENT ASPIRIN", "stdName": "PERCODAN COMPONENT ASPIRIN", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "46e82f2b-8ec5-4d3a-8039-62ba0f7ab34d", "5aa6dab6-399a-42e6-842f-e6f848c7b832" ], "display_name": false }, { "uuid": "a0b52bae-9f24-4875-8e29-6ecf62b960da", "name": "PERCODAN-DEMI COMPONENT ASPIRIN", "stdName": "PERCODAN-DEMI COMPONENT ASPIRIN", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "46e82f2b-8ec5-4d3a-8039-62ba0f7ab34d", "5aa6dab6-399a-42e6-842f-e6f848c7b832" ], "display_name": false }, { "uuid": "63213dab-2142-49da-bb5f-59540b974cda", "name": "PL2200 component aspirin", "stdName": "PL2200 COMPONENT ASPIRIN", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "c158dafb-4266-4861-b401-c4287559b672" ], "display_name": false }, { "uuid": "66ab5393-897a-4839-8f1b-6794f0e8fe17", "name": "PRAVIGARD PAC COMPONENT ASPIRIN", "stdName": "PRAVIGARD PAC COMPONENT ASPIRIN", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "46e82f2b-8ec5-4d3a-8039-62ba0f7ab34d", "5aa6dab6-399a-42e6-842f-e6f848c7b832" ], "display_name": false }, { "uuid": "9f28e8e0-ed43-42c7-9e42-201bb5d2d761", "name": "Q-GESIC COMPONENT ASPIRIN", "stdName": "Q-GESIC COMPONENT ASPIRIN", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "46e82f2b-8ec5-4d3a-8039-62ba0f7ab34d", "5aa6dab6-399a-42e6-842f-e6f848c7b832" ], "display_name": false }, { "uuid": "bef3fe34-dc05-471e-8127-bab5eecd4fc9", "name": "ROBAXISAL COMPONENT ASPIRIN", "stdName": "ROBAXISAL COMPONENT ASPIRIN", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "46e82f2b-8ec5-4d3a-8039-62ba0f7ab34d", "5aa6dab6-399a-42e6-842f-e6f848c7b832" ], "display_name": false }, { "uuid": "458a73b6-bb43-442b-b527-034d3c9ba323", "name": "ROXIPRIN COMPONENT ASPIRIN", "stdName": "ROXIPRIN COMPONENT ASPIRIN", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "46e82f2b-8ec5-4d3a-8039-62ba0f7ab34d", "5aa6dab6-399a-42e6-842f-e6f848c7b832" ], "display_name": false }, { "uuid": "b51beed2-5b0e-4b9f-ad9f-5fed3f301ba4", "name": "SOMA COMPOUND COMPONENT ASPIRIN", "stdName": "SOMA COMPOUND COMPONENT ASPIRIN", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "46e82f2b-8ec5-4d3a-8039-62ba0f7ab34d", "5aa6dab6-399a-42e6-842f-e6f848c7b832" ], "display_name": false }, { "uuid": "80361675-9c34-4f4a-8136-f808abe2f4c7", "name": "SYNALGOS-DC COMPONENT ASPIRIN", "stdName": "SYNALGOS-DC COMPONENT ASPIRIN", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "46e82f2b-8ec5-4d3a-8039-62ba0f7ab34d", "5aa6dab6-399a-42e6-842f-e6f848c7b832" ], "display_name": false }, { "uuid": "9e36ce8a-89e5-4b17-9cbf-c8eb8cbf442b", "name": "Salicylic acid acetate", "stdName": "SALICYLIC ACID ACETATE", "type": "sys", "languages": [ "en" ], "preferred": false, "references": [ "9bff8ba8-0ef5-4c4d-97de-48ec020106b7" ], "display_name": false }, { "uuid": "fb26bbaf-70b2-47ed-b2b5-f892793ae0ef", "name": "TALWIN COMPOUND COMPONENT ASPIRIN", "stdName": "TALWIN COMPOUND COMPONENT ASPIRIN", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "46e82f2b-8ec5-4d3a-8039-62ba0f7ab34d", "5aa6dab6-399a-42e6-842f-e6f848c7b832" ], "display_name": false }, { "uuid": "a65349f3-a996-4ceb-aee3-24d1f1628d72", "name": "VICOPRIN COMPONENT ASPIRIN", "stdName": "VICOPRIN COMPONENT ASPIRIN", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "46e82f2b-8ec5-4d3a-8039-62ba0f7ab34d", "5aa6dab6-399a-42e6-842f-e6f848c7b832" ], "display_name": false }, { "uuid": "d573ac01-3c42-42ec-890c-4b0222780875", "name": "YOSPRALA COMPONENT ASPIRIN", "stdName": "YOSPRALA COMPONENT ASPIRIN", "type": "bn", "languages": [ "en" ], "preferred": false, "references": [ "745256bc-b919-4ff3-b3f2-e6ff4c6c7e77" ], "display_name": false } ], "modifications": { "uuid": "94231f96-790b-4e07-878d-911f5630b3fb" } } ] }